gentral rate contract no. - 143(c) - for supply of drugs & dressings

FOR SUPPLY OF DRUGS & DRESSINGS

(VALID FROM 14th October,2021to 31"t October, 20231

STR]CTLY FOR OFFICIAL USE

EMPLOYEES' STATE INSURANCE CORPORATIONROOM NO.312 & 314, HQRS. OFFICE, PANCHDEEP BHAWAN

C.I.G. ROAD, NEW DELHI- 110 OO2

DRUGS FOR RESPIRATORY SYSTEM

DRUGS FOR CARDIO-VASCULAR SYSTEM

DRUGS ACTING ON CENTRAL NERVOUS SYSTEM

ESICGENTRAL RATE CONTRACT NO. - 143(C)

2A2L-2023

ESICCENTRAL RATE CONTRACT NO. - 143(G)

FOR SUPPLY OF DRUGS & DRESSINGS

(VALID FROM 14th October,2021to 31"t October' 20231

2*2:"-2*23

PUBLISHED BY

DIREGTOR GENERAL

EMPLOYEES' STATE INSURANGE CORPORATION-ioon No.312 &314,HQRS. oFFlcE, PANcHDEEP BHAwAN

C.I.G. ROAD, NEW DELHI- 110 OO2

RYRAT MTESSYoISE PRRFS oUR GD

DRUGS FUS SYSTEM

DRUGS ACTI

STRICTLY FOR OFFICIAL USE

SYSTEM

Sno. Contents PageNo.

1. Fonararding letter along with terms &conditions for operation of Rate GontractNo. 142 (C).

t-x

2. List of Approved Pharmaceutical firms.

?,FtA R*- - a4/rrl

1-3

3 Address with Terms & Conditions of theEligible firms

1-17

4. lndex 1-8

5. Rate Schedule

=i,.) ) 1)O)A

1-50

.e=

STRICTLY FOR OFFICIAL U SE ONLY

offirrqffcrfurc('Ic Fi {tsqE dililq, qna wiFrgEMPLOYEES' STATE INSURANCE

CORPORATION(Ministry of Labour & Employment, Govt. oflndia)

ITqTdq/HEADQUARTERS'riq{q rr+q, S"qdd rn f, +{ ffi - r ro oozPanchdeep Bhasan,C.I.G' Matg,New Delhl-110002

www.esic.nic.in, 80 1 1-23234334,8 dmc-rdaresic nic.in

^4^W,#r*tHtdd

No.U-ZslLzlt42C-1 202t

From

The Director General,E.S.I. Corporation,

Panchdeep Bhawan,

C.I.G Road,

ToDirector (Medica

Dean,

Medical

Director, ESI

Sub r

Sir / Madam,

Please flnd

supply of drugs and

Validity of this i.e. w.e.f,

14.1O.2O21 to 31'10'20

Further, the following terms

Contract:-

operation of the Rate

1. ImmediatelY on receipt of this communication, the Chief Direct Demanding Officers

(Director/Addl. Director/J I Officer/Diredor

Medical) Delhi & Noida shal and the officers who

have been designated as ration of this

Rate Contract on his beha toa ntract ers. Contract holders

would entetain the suPPlY orders & related correspondences from the officers working as

DDOs only after the receiPt of such communication from the Chief DDOS.

RC

for

(

I

rl

Colleges & Hospitals,

PURCHASE OF DRUGS AND DRESSINGS

CORPORATION CENTRALISED RATE CONTRACT

FROM 14.10.2021 TO 31.10.2023 .

UNDER THE E.S.I.

NO. 143C EFFECTIVE

the Rate

ECI(

2 supply orders will be placed by Heads of ESI Scheme of various states/ Deans/ lt4edical

Superintendents, ESIC [vlodel Hospitals, who for the purpose of this Rate Contract, shall be

designated as chief Direct Demanding officer and will exercise the powers of Director

General, ESI Corporation in all matters connected with the execution of supplies and / or

wherever specifically provided in the terms & conditions of the Rate Contract' The Chief

Dlrect Demanding Officer can also designate any of his subordinate officer as Direct

Demanding Officer (DDO) to operate this Rate Contract.

All the supply orders shall be signed only by the officers who have been duly authorised

and included in the:.list of'DDos.-DDOs-.will send rynn4{.9py of the Purchase

order through email.followed, by speed post directly tothe firm' ',

':: ', . -..:1.

The Chief DDOs may bring to the notice of the undersigned the discrepancies (especially in

rate, packing, composition of the drug) if any observed by them'

J

4

5. The Chief DDOs shall monitor

to their execution of suPPlY

supply report along with th

6. The applicabilitY

of the Ra

ilsasun

holding flrms in regard

ated quaterly non-

nder this

rates.

Act or

t necessary

ithin 4-6 week

B

9

supply orders will be placed from time to time during the currenry of the contract in which

tt-ili.a qrirtities required on each occasion together with the date. of delivery shall be

specifiedbytheDirectDernandin$.officers..,..i.....l'l

No guarantee can be given..as io the.,minimim quantiry frntir iritt be.di'awn against thls

.ont"ru.t but the pharmaceutical firm will supply quantity as may be ordered by the Dlrect

Demanding Officers during the currenry of the contract

l0.supplyordersagainstthecontractwillbeacceptedaslongasthesereachthepharmaceutical firm on or before last date of the currency of the contract' Supply orders

received during the closing days should be complied within due course, in accordance wlth

the contract iieven thoug'h in some cases owing to contract having expired, supplies are

to be complied with even;fter the expiry of the last date of the contract'

Qty. notsupplied

R.C.

No.

Item No. &Name of

Drug

7.

l

51 2

II

7. It will be ensured beford'placing ordqr. by the

funds are available and PaYment be arranged

time of the execution of the orders bry.the Rate

unnecessary delay in the payment of their bil!5: 'Contract Holder and there should not be

RemarksPaymentif

pending

RiskPurchase/

penaltylevied

withDate

Name of S.O..:No;

firm

8.6.3.

11. Notwithstanding any omission or shortcoming in the supply order it is incumbent upon the

Pharmaceutical firm to supply the item as per the specifications of the relevant rate

contract.

SUPPLIES

12. The purchaser will not pay separately for transit insurance and the contractor will be

responsible for delivery of items covered by the supply order in good condition at the

specified destination and for this purpose freight, insurance, Octroi etc, if any, will have to

be borne by the supplier. {he consignee'will, as-soon as po:qible, but.iiot later:than 30

days of the date oi arrival of stores at destination, notify the contractor of any loss or

damage to the storei,,that ma, lilve occurred ilu.ring thertr.anSiL ''.'..,.,' '... ,''

b) Loose supplies/damaged packing/tempered or damaged labeled supplies shall not be

accepted under any cireumstancest''a

c) Supplies to be made in, propeir boxes' . -i. - l

d) Liquid orals to be supplied only in glass/ plastic bottles conforming to Drugs &

Cosmetics Act and rules made there under.

e) Large volume parenterals to be quoted and supplied only in plastic bottles / polypacks- conforming to Drugs & Cosmetics Act and rules made there under'

III

shall beAct,

drug must2009 and

13. During transit pharmaceutical firm should maintain the recommended

temperature of the drug (wherever indicated), otherwise if on checking it is

found that temperature has not be€n mairitaind, supply,?gainst the said order

is liable to be rejected and cancelled. It will ber"counted as t non-supply.

14. The prices approved are FIO,R. Destination per unit and are exclusive of GST except

where indicated but inclusive of.all charges for packing and forwarding.

15. In all contracts for items/ drugs, which are branded with 'ESI SUPPLY' mark including

rejected items/ drugs, it would be a condition that such items/ drugs will not be sold to the

public/open market.

16. Marking:

Each packing shall be printed with nomenclature of the

labelled in accordance with the1940 and the rriles iiiade theie under.

comply with the procedure provided under the Legal

Drugs

rules made there under.

17. Packing:a) rt s[ould be ensured that all labelg-,of cartons, ampoules,'vialg bottles, jars,

tubes, tins, containers etc.i. have "For ESI rypply, Not to be sold"

imprinted/rubber stamping with indelible irlk clearly. Any consignment

wiihout such stamping will not be considered valid and will be rejected.

fl It should be ensured that only firct use packaging materia! of uniform size

including Bottles and vials should be used for making supplies on the basis of ESI

Rate Contract.

g) All primary packing containers should be strictly conforming to the specifications

described/ mentioned in the relevant pharmacopoeia.

h) Packing should be able to prevent damage or deterioration during transit.

i) All containers i . ei, bottles,.tins; carto$g tubes etc', are required tor-be secur€d with

pilfer-proof sealito ensurergenuinenels of the products packed and the corredness of

the contents. MRP should not be written on any labels othdriiVise,.itwill disqualified.

b)

c)

19.

Act.

20. The Stores accePted sh

1940 and the Rules m

Order.

mentioned against each

srons of Drug and Cosmetics

ould comply

ade thereunWithtiiir a

the provisions of-the Drugs ?nd Cosmetics Act,

s amended llpto latb and Drug Price Control

21. It should be ensured that IsI code No, is indicated on the packing and at the time of

supplies, it must be ensured that the items supplied has ISI Mark as well as code No.,

as ls the statutory requirement of the Bureau of Indian standards'

IV

18. Life Period :

.) For Drugs having shelf life of Two years or less: As on the date of delivery,

Drugs should noi be older than one fourth (1/a) of its shelf life from the date of

manufacture.

For Drugs having shelf life more than Two years: As on the date of delivery,

Drugs s[ould noi be older than one sixth (U6) of its shelf life from the date of

manufacture.

Imported Drugs: As on the date of delivery, Drugs should have a minimum

500/o of valid shelf life from the date of manufacture.

rm!

sEores a

22, Testino of Drugs - Oualitv Control

a. Approved Rate contract Holder should submit a Test Repoft that particular

bitch of medicines tested by the Governmenv Government approved

Laboratories (as per list circulated from ESIC Hqrs/ Hospitals/ state Govt. from

time to time) along with each supply.

b. The Director General, ESI Corporation shall be at liberty to undeftake regular

at the time of suoPlv

t

I If any drugs supplied against this Rate Contract are

standard quility on inspection by Competent Authority, th

will be liable to replace the entire quantity within 15

purchase will be charged from the,Pharmaceutieal firmt

If the product is found t6 be.'not'.of standdid. quality','the

recovered from the suPPlier.

If standard quality is not maintained in h'l'o batches in two years

duration of the rate contract, the drug of the that company will be

ur""[ri"t a and debarred from running in Esrc rate gg!tE!g!-&u!

oeriod of three vears.

found to be not of

e pharmaceutical firm

days othenarise risk

.1,

cost of testing will beh

and random testing of the drugs supplied by the pharmaceutical

regular interval.to maintain and ensure the aUllitY of'drugs.r

d.

c. The Chief D.D.OS may get at least l0o/o of the drugs tested

Laboratory, or in anY of the Govt. Approved laboratories' Instructions issued in

this regard from Hqrs. Offlce time to time.may please be adhered to'

Details of the items found not of standard quality should be brought to the

notice of the undersigned along with the test reports immedia!-'ly. All such test

reports should necesaarily come through Chief D'D.Os only. A'topy of the..test

report shou!(,be sent immadiately !o the firm, the'cbncerl9! Drug controllers,

and respectiVe Central Drug. Contrrjl authorities for necesaary''actloni'

23

bv ESIC for each categorv of defects, described as under:-

be initiated by the DDO's wherever payment had been made alrea(y, ..

Forfeiture offefoifr'ance Securiffim the respeitive,DGESICRqIe €ontract for all

the quoted drugs.

Debarring of tire Rate'contiact holdei / Pharmaieutical- firiir from current and all

Iries

II. If

a

pharmaceutical firm is

Recall of the NSQ item imm ta

CateggryBwithinaYearESIS User Units. Recoveries

to be initiated by the DDO's wherever payment had been made already'

. Fofeiture of Performance security from the respective DGESIC Rate Contract

for all the quoted drugs'

o Rate Contract Holdef Pharmaceutital firm will 6e {ebarred fidr further supply of

the said NSQ item in the currency of the Rate contract'

. Debarring of Rate contract Holder/ Pharmaceutical firm immediately from

current and all future DGESIC Rate Contracts for a period of three years'

. Rate Contract Holder/ Pharmaceutical firm will be liable to pay damages/

compensation(ifany)toindividual/individualsarisingduetoconsumptionofitem declared NSQ and in case of any adverse reaction reported in the Hospltal

during administration of the drugs.

VI

A. CATEGORY'A'DEFECT (Spurious / Adulterated Drugs)-

If any item / Batch of the item declared Not of Standard qualiU (NSQ) under

Category A .. Recall of the NSQ item immediately from all ESIC/ ESIS User Units. Recoveries to

future DGESIC Rate Contract for a period of five (5) years.

. Rate Contract Holder/ Pharmaceutical firm will be llable to pay damages/

compensation (if any) to individual/ individuals arising due to consumption of item

declared NSQ and in case of any adverse reaction repoted in the Hospital during

administration of the drug.

B, CATEGORY'B' DEFECT (Grossly Substandard Drugs)

C CATEGORY' C' DEFECT (Minor Defects)

I. If single item/ Batch of item is declared NSQ under Category C

. Recall of the NSQ item immediately from all ESIC/ ESIS User Units. Recoveries

to be initiated by the DDO's wherever payment had been made already.

. Forfeiture of Performance Security from the respective DGESIC Rate Contract

for that drug.

. Rate Contract Holder/ Pharmaceutical flrm will be debarred for futher supply of

the said NSQ item in the currency of the Rate-contract. ..-,,- .r .:-.,.

o Rate Contract Holder/ Pharmaceutical firm Will -be liable to pay damages/

compensation (if any) to individuali individuals arising due to consumption of

item declared NSQ and in case of any adverse reaction repod€jd in the'Hospital

during administration of the drugs.

u. If more than one item ing to any individual

pharmaceutical firm i NSQ u C within a year

Recall of the N nits. Recoveries

to be in already.

Fofeitu Security Rate. Contract

for all the rugs.

supply of

from

ages/

of

ospital

a. Delivery of si

by email a in stipulated

time.

b. If the pharmaceutical firm e supply order within the

stipulated period of six weeks, a penalty of two (2) per cent of the va lue of

the order catculated at the contract rate per week or a part of a week wi ll be

levied. The maximum 10% of the

total extension of

the d ding Officers,

if itpermissible for a maximum period of 5 week only but penalty will be levied.

a

24.

VII

weeks from of the P.O. sent

for late

a extension isituI

In case of failure to supply, the Corporation reserues the right to purchase

the stocks from other sources as risk purchase, i.e' purchase from any other

pharmaceutical firm or firms, in the rate contract or from outside the contract

at the discretlon of the Direct Demanding Officer concerned at a competitive

rate or from local chemist.

That extension of deliverv oeriod cannot be claimd as a malter ofrioht but will be at the discretion of con@med cttricen

If the iterns/ drugs

or by the ,extendednot suppiieii is I

ot suppli

) full o1to be

d (as i

the sk

ect

an

ndicated above

of,lhe quantity

d expense of

d are n'date

iable

e

25. Quoting

a.

pharmaceutical firm. The extra expenditure involved in procuring supplies

from elsewhere i.e. Local Pu rm/other running Govt. Contract etc',

in that case, will be utical firm, in full atthus due will be

Officer or which ator any other

He will be

tion in

n, the

bidd deposit invite

other from Rate

reentrynextgof

edule

rges.

b. GST, if extra, where legally leviable and intended to be claimed, should be

distinctly shown separately alongwith the price qu.oted.. where this is not done,

no cfaim of GST will''be aamtea at anyt tatAi stdile 6iiQ on any ground

whatsoever,

\NII

c.

L'

26. Pavment

27.

30.

31.

32

Payment for the supply will be made within 4 to 5 weeks (after receipt and

aiieptance of the diugs/items) directly by the Direct.Demanding Officers or

through nominees to w6om bills are submitted. Notwithstanding any omission or

in"riC'o.i.g in the supply order it is incumbent upon the pharmaceutical

fii./UtOaeito supply the items as per the specifications of the relevant rate

coniract. No claim ior the payment from contractor shall be entertained after the

lapse of three years of arising of the claim.

Any dues or payments that have arisen to the Corporation from the

pharmaceuticalfirmforwhichnospecifictimelimithasbeenlaiddowninthe

terms and conditions shall be payable by the pharmaceutical firm within such time

limitasmaybeprescribedintheletters/ordersaddressedtothepharmaceutical

firms.

Any payments that have been demanded as per the provisions of above

mentionedclauseorunderanyotherclauseshallbepayablewithinthetimelaiddown. On failure to do so: -

. The pharmaceutical firm shall be liable to be debarred for supplying items/

drugi etc. to the Corporation for a period not exceeding three years'

. The Corporation reserves its right to take appropriate legal action against.the

;;f;rlti;g fiils as may be le{ally advised, including claim for compensation

unJaurig.t for the period oldelay and / or simple interest 10o/o per annum

for each daY of default'

RateSchedulealongwithlistofitem.wisefinalizedrates,alongwith.nameofthe;;;;";;; nrr* is ericlosed. In regard to items where rates of more than one firm

nll. U... .pptoved, order shouli be placed to the firm at First Preference and

whose rates are the lowest. In case oi non-supply by such firm, order shall be

pf.i.J t" tn" firm with the next higher approved rate invoking risk purchase'

No other document should be entertained for giving any cognizance for placing the

supply orders.

Acceptance letter issued to the firms by this office cannot be used for placing

orders.

it"t!N, under Ministry of Labour'& employniEnt has granted exemption .to

operaie'OCSfC Rate Contract for drugs and dressings as per Minutes o-F^the

nieeting vide office Memorandum no. z-i0025 l25l2ol7-Adm II dated 29.01.2021.

IX

28,

29.

33

34 It shall

Encl.: As above.

All Chief Di

information

all DDOs u

send the list

PPS/PS to Di

PPS/PS to Fi

PPS/PS to Medical

Medical Administration

Accounts Branch -V (Hq

has come to an end or ceased to exist.

Force Majeure:- -if rf .ny time during the applicability of Contract the bidder fails to discharge its

OUfiguiion due to f6rce maieure (natural disaster. or act of God etc') he will

p.,ipuv notify the Director'General or its representative about the happening of

iuctr'an eveni. The Director General or its representative is solely engtlqd to

i"*init"l determine the order/contract in respect of such performance of .the-

UiaO"rirl'oUfigutlons if he so desires. The obligations under the contract on behalf

of biddei for the contract shall be resumed as soon as practicable after the event

Indruglevel with strict control as per ABC-VED matrix and

formutary of the respective institution is followed in right earnest to

provide medical services to

This issue with the a

ity of of

s foron9

to

I Education /

Copy tor

1

2

3

4

5

Dv. Medical Commissioner (RC)

Forr DTRECTOR GENERAL

202L-2023

x

Yours faithfullY,

/<Dy. Medical Commissioner(RC)

FOT: DIRECTOR GENERAL

Approved Vendor List 143C

Name of the FirmSNo,

Abbott India Limited1

Healthcare Limited2

Baxalta Bioscience India Private Limited3

Baxter4

m5 Bharat

heim India PrivateInBoeh6

7

8 LimitedCi

P9

Emcure10

FDC Li11

tz

13

Habt4

Hindustan15

Intas16

ofluggat Pharma

Pharma D leI77

Lark Laboratories ndia18

Macleods Pharma19

Ltd20

Mesmer Pharmaceuticals2L

Micron Pharmaceuticals22

Page 1of 3

Ltd

Ltd.

'l


Name of the FirmSNo.

re Pharmaceuticals ht. Ltd.Midas G23

Prlvate LimitedModi Mund24

Overseas Healthcare h/t Ltd25

26 Pfizer Lim

Pfizer Prod27

AA LtdPrecise Chemi28

India29

Pulse30

31 Revat La

Roche32

iPa33

Sanofi -34

Sanofi I35

Serdia36

37

Sun Pharma La38

LimitedTablets39

Themis Medicare Limited40

Troikaa Pha47r

USV Private Lim42

Virchow Biotech h/t. Ltd43

Wallace Pha rmaceutica ls h/t. Ltd.44

Windlas Biotech Private Limited45

h . Ltd.Zenith46

Page 2 of 3

*

tatt

)rar(

(aIl

rs*t Kffi r43{c}


Name of the FirmSNo,

47 Zim Laboratories Limited

48 Zuventus Healthcare Limited

care LtdS49

Page 3 of 3

vendor NameABBOTT INDIA LIMITED

3 Corporate Par( Sion Trombay

Road, Chembur Mumbai 400071

Mobile/ Tel No:9987072315 /(91-22) 38160s27

Fax No (if any): (9

Email: institution.busin

1-22) 38162401

[email protected]

II,.

s63 I

Vendor NameBA]AJ HEALTHCARE LI

602-606, 6th Floor,

Infotech Park, Plot

No. 23, Above IIndustrial Estate,

Mobile/ Tel022-66t77400

Fax No (if any):Email:

Vendor NameBAXALTA BIOSCIENCE IPvT. LTD

6th Floor, Building no. 8, Tower C,

DLF Cyber City, DLF Phase

Gurgaon 122002 Haryana

Mobile/ Tel No: 8448815

0124-4559100

Fax No (if any): 0125-4559109

Emailt [email protected]

Term 1 Delivery within 6(six) weeks (of the actual date

of dispatch) of supply order on FOR Destinatlon

basis

Term 2 GST as applicable will be extra except for items

where no tax has been approved.

Term 3 If at any time documents submitted/information given by the flrm in the tender is

found to be false/ erroneous, the award will be

cancelled.

'Teim 4 Supply to be made direcUy.

weeks (of the actual date

er on FOR Destination

where no

except for items

submitted/tender is

will be

lirectly.

order on FOR Destination

(of the actual date

Term 2

Term 3

GST as applicable will be extra except for items

documents submitted/the firm in the tender is


cancelled.

n s

approved.

Term 4 Supply to be made directly.

Page 1 of 17

Term 1

Term 2

'Term 3

Term 4

Term 1

where

Vendor NameBAXTER INDIA PRIVATE

LIMITED

5th Floor, Tower-A, Building No. 9,

DLF Cyber City, DLF Phase III,Gurgaon-122002, Haryana

Mobile/ Tel No:9810592367 /0Lz4-4200200

Fax No (if any): 0tZ4-+20020

Email: [email protected]

baxsolutions [email protected]

Vendor NameBHARAT SERUMS AND

VACCINES LIMITED

3rd Floor, Liberty Tower, Behind

Reliable Plaza, Airoli, Navi Mumbai -

400708

Mobile/ Tel No: 9910025803 /022-45043476

Fax No (if any): 022-45043200

Email:vishwadeep,[email protected]

[email protected]

[email protected]

sunny,[email protected]

Vendor NameBOEHRINGER INGELHEIMINDIA PRIVATE LTD

1102, 11th Floor, Hallmark Business

Plaza, Gurunanak Hospital Road,

Near Gurunanak Hospital, Bandra -,,.,':..

East, Mumbai, India - a0005,f..,

Mobile/ Tel No: 9311210727 /9t-22-264564779t-22-7t456477Fax No (if any): 9I-22-71456766Email: ratan.sharma@boehringer-

ingelheim.com

[email protected]

Delivery within 6(six) week (of the actual date

of dispatch) of supply order on FOR Destination

basis



Term 3 If at any time documents submitted/information given by the firm in the tender is

found to be-false/,erroneous, the award will be

cancelled.

Term 4 Supply to be made direcdy.

Term 1

Term 2 GST as applicable will be eara except for items


Term 3 If at any timeinformation given by

documents submitted/the firm in the tender is


cancelled.

Term 4 Supply to be directly.

Term I Delivery within 6(six) weeks (of the actual date

of dispatch)-of supply order on FOR Destination

basis



.Terrh 3 : tirne.'.. documents su

information given by the firm in the tender is


If at .. ahy bmitted/

cancelled

Term 4 Supply to be made directlY.

Term 1

Delivery within 6(six) weeks (of the actual date


basis

made

Page 2 of L7

Vendor NameCENTAU R PHARMACEUTICALS

PvT. LTD.

Centaur House, Shanti Nagar,

Vakola, Santacruz East, Mumbai -

400055.

Mobile/ Tel No:' 9820244293 I02266499270 /0

Fax No (if any):Email: institutions@

IC.com

[email protected]

Vendor NameCIPLA LIMITED

Cipla House Pen

ParK Ganpatrao

Parel, Mumbai-

Mobile/ Tel N8874450173 I022 24826000

Fax No (if any)[email protected]

Vishwas.Ahuja@Cipla

Vendor NameConcept PharmaceuticalsLimited

801, Hubtown Solaris (entrance

From B Wing) N S Phadke Miirg, OffTeli Galli, Near Andheri Flyover,

Andheri (East), Mumbai-400069

Mobile/ Tel No: 9891249600 /022- 42418888

Fax No (if any): 022- 42418888


[email protected]

Term 1 Delivery within 6(six) week (of the actual dateof dispatch) of supply order on FOR Destination

basis




..founQjo be false/ erronequs, the award will be

cancblled.iTerniS Supply- to be made directy.

/eeks (of the actual daterrder on FOR Destination

for itemsr except'ed.

tender is

rd will be

submitted/

weeks (of the actual date


s

su pply

Term 2

11"


where notax has been approved.

Term 3 If at any time documents submitted/

information given by the flrm in the tender is


cancelled.


Page 3 of 17

Term 1

Term 2 GST

,.Term 3

Term 4

Term 1

Vendor NameEMCURE PHARMACEUTICALSLIMITED

Survey No. 255/2, Phase I, Rajiv

Gandhi IT Park, MIDC, Hinjawadi,Pune - 411057

Mobile/ Tel No:9830890292 174020 39821000

Fax No (if any):Email: [email protected]

[email protected],in

anil.arora@emcure,in

Vendor NameFDC LIMITED

142-48, S.V.

(West) 400102

9970009897 /9830890292,7 4287 74333 I 020 39821000

Fax No (if any): 020 39821020


[email protected]

[email protected]

9370130077,

287t433j

020 39821020

Survey No. 255/2, Phase I, Rajiv

Gandhi IT Park, lvlIDC, Hinjawadi,

Pune - 411057

Mobile/ Tel No: 9370130072,

Term 1 Delivery within 6(six) week (of the actual dateof dispatch) of supply order on FOR Destinationbasis

Term 2 GST as applicable will be extra except for itemswhere no tax has been approved.

Term 3 If at any time documents submitted/n the tender is

award will be

Terrh 4-

ks (of the actual date

3r on FOR Destination

xcept for items

L

submitted/e tender is

rd will be

ctly.


(of the actual date



If .-tatr: any .rtime documents submitted/information given-by the firm in the tender is

found to be false/ erroneous/ the award will be

cancelled.

Term 4 Supply to be made directly,

Page 4 of L7


I 8554925907 97-22 267 3937 7

Fax No (if any): 022-26773462


Vendor NameGennova Biopharmaceticals Ltd

SupDli to be re(

1Term

Term 2

3Term

Term 4

Term 1

Terii,r 3

Vendor NameGOPAL DAS VISRAM ANDCOMPALNY LIMITED

8, Fida Building, 18 Shamaldas

Gandhi Marg, Dawa Bazar, Mumbai :

400002

Mobile/ Tel No: 98

022-2240t7281 99


Vendor NameHAB

RESEARCH LTD

Fax No (if any):Email: marketing@

Vendor NameHINDUSTAN LABORATORIES

LIMITED

Mobile/ Tel No:7710055194 /98207 87 s58 I 02242460500,42460526

Fax No (ifany): 022-42460531


kunjaldedhia@hindlab,com

A-302, Victory Park, Chandavarkar

Road, Borivall (West), lYumbai -

400092, Maharahstra

C

Term 1 Delivery within 6(six) weeks (of the actual dateof dispatch) of supply order on FOR Destination

basis



Term 3 If at any time documents submitted/n n the tender is

award will be

ca

Term 4 Supplfto be mate directli.'

(of the actual date

on FOR Destination

pt for items

wheft

erm 3 anyIf at submitted/tender is

rd will be


(of the actual date

GSI as.applicable.Will be extra except for ite

where no tax has bedn approved.

ms

Term 3 documents submitted/



cancelled.

Ifata


Page 5 of 17

308 3rd Floor T.v Industrial Estate

S. K Ahire Marg Worli Mumbai 30

Mobile/ Tel No: 9930212908 /022-66267409

Term 1

Term 2


Term 1

2tTgrm

Vendor NameINTAS PHARMACEUTICALS

LIMITED

Corporate House, Near Sola Bridge,

S.G. Highway, Thaltej, Ahmedabad-

380054


Vendor NameJuggat PharmaDivision ofPrivate Limited)

No.782, 15th

J.P.Nagar,

Bangalore - 560

Mobile/ Tel No26635026,

Fax No (if any):Email:[email protected]

Vendor NameLARK LABORATORIES (INDIA)LTD.

Mobile/ Tel No:079-39837000

932802s602 I

A-105 12, Okhla Industrial

Phase-Il. New Delhi-110020

Fax No (if any): 9l-7492-225137Email: [email protected]

[email protected]

Term 1 Delivery within 6(six) week (of the actual date


basis



Term 3 If at any time documents submitted/n the tender is

award will be

Term 4 Supply to be made dirbctly.

(of the actual date

FOR Destination

award will be

submitted/tender is



basis

Term 1

Term 2 GSf;arppiicable wiil be extra except for items

where no tax has been




cancelled.


Page 5 of 17

Mobile/ Tel No:9811023731 /0tt-407L7777

Term 1


where no tax has been approved,Term 2

If at any time

information given by

found to be false/ erroneous/

cancelled,

Term 3


oo(

Vendor NameMACLEODS PHARMACEUTICALS

LIMITED

Atlanta Arcade, Marol Church Road,

Opposite Leela Hotel , Andheri

(East), Mumbai - 400059

Mobile/ Tel No: 8

98678680021 022

Fax No (if any): 0


oshukla@macleodspharma,com

Vendor NameMEDLEY

LTD

Add - Medley ho

Andheri (E), Mu

Vendor Name

MESMER PHARMACEUTICALS

Vedha No 13, Mangala N

Main Road, Porur, Chennai-

600116,Tamil Nadu.

Mobile/ Tel No: 9444903427 I044-22522678

Fax No (if any): 044-22522592


tenders.mesmer@iconlife,in


of dispatch) of supply order on FOR Destinationbasis


where no tax has been approved,

Term 3 If at any time documents submitted/the tender is

award will be

(of the actual date

FOR Destination

for itemsTerm 2 G.ST as applrcwhere no tax h

Term 3

rd will be

submitted/e tender is



basis

::Term 2 GsTiatappliciiUlel^iill be extra except for items

w.lerelo91nas b€qt approved.

If at any time documents submitted/information given by the firm in the tender is


cancelled.

Term 3


I

Mobile/ Tel Not 93222M643 I982103 1003/022 687 57 57 5

Fax No (if any): 02228204453

Email : [email protected]

[email protected]


Term I


Page 7 of 17

Vendor NameMICRON PHARMACEUTICALS

Plot no 2117 A-2 Phase III GIDC

Vapi 396 195

Mobile/ Tel Nor 9924170750 /9820081388/ 0260 74054001

0s106107

Fax No (if any): 0260 2405479Email: [email protected]

sales@m icronpharma.in

vendor NameMIDAS CARE

PHARMACEUTICALS PvT. LTD

Lotus Corporate Par( B Wng, 3rd

Floor, Jay Coach, Graham Firth

Compound, WE Highway, Goregaon

(East), Mumbai 400063

Mobile/ Tel No:9867478316 /022-42193900


[email protected]

Vendor NameMODI MUNDIPTIARMA PRIVATELIMITED

1400, MODI TOWER, 98, NEHRU

PLACE, NEW DELHI-110019

Mobile/ Tel No:9810203582 /011-4250 4555, 011 4250 4992



basis





basis





cancelled.

Supply to be made directly.



basis

Term 2 GST' as applicable will be extra except for items

where no tax has b€en approved.



cancelled.

Term 4

Page 8 of 17

,

Fax No (if any): 011-2645 1659


arvindmadan@modimundipharma,com



cancelled.

Term 4 Supply to be made direct]y.

Term 4

l.l ,lrI'\ar-t


Vendor NameOVERSEAS HEALTH CARE PvT.LTD.

335Km Milestone, National Highway

No.1, P.O. Box 25, Phillaur, District

Jalandhar, Punjab State

Mobile/ Tel No: 9872019733 /07826-222886

Fax No (if any): 07826-222885

Email: info@overseasheil$rcarri.io.in

[email protected]

Vendor NamePFIZER LIMITED

The Capital 1802/

70, G-Block, Ba

Bandra (E) Mum

Mobile/ Tel97714t47561

Fax No (if any)Email:

Rajesh.kadian2@pfizer

Satendra.seth@pfizer

Vendor NamePFIZER PROCUCTS INDIA PVT

LTD

The Capital 1802/1901, Plot No. C-

70, G-Bloc( Bandra Kurla Complex,

Bandra (E) Mumbai - 400051

Mobile/ Tel No: 9771414156 i2266932000

Fax No (if any): 2226540274

Email:GOVERNN4ENTTENDERSPPIPL@pf izeT,com

[email protected]

Satendra.seth@pf izer,com



basis





,found.to be felse/ erroneo-us, the award will be

cancelled. ' i'Ter.!:nt Supply'to be made directly.

eeks (of the actual date

rder on FOR Destination

for itemsr exceptred.

submitted/tender is

will be

Ddlivery within 6(six) week (of the actual date


basis

for itemsaar.T 7

Term 3 If at any time documents su



bmitted/

cancelled.

Supply to be made directly.Term 4

Page 9 of 17

Term 1

Term 2

3Term

4

found to be false/

Term L

approved,

Vendor NamePRECISE CHEMIPHARMAPvT.LTD

Offlce No. D-4, Neelkanth Business

Park, Nathani Road, Vidyavihar(West), Mumbai - 400 086

Mobile/ Tel No: 98191-49266 /91-22-68783333 ., t,

Fax No (if any): 91-22tir83333Email : [email protected]

Vendor Name -.:.

PSYCHOTROPICS II{DIIA]LIMITED

Plot No. 17, Sector- 20 A,

Faridabad-121001

0t29-228269t

Fax No (if any): 0L?9-2296764


Vendor Name r',t;

PULSE PHARMACEUTICAT PVT

LTD

Plot No: 18/1, Sector III, HUDA

Techno Enclave, Hitech City,

Hyderabad - 500 081.

Mobile/ Tel No: 9346155755,

9311083087 /97-40-23t79992Fax No (if any): 91-40-23119992


[email protected]



basis



Term 3 If at any time documents submitted/information.given ,by the fffn jn the tender is

found to bdftlse/ brrdnq0us, tlie award will be

cancelled.

Terit 4' pply to be made directly.'Su

livery within 6(six) weekof dispatch) of supply order on FOR Destination

(of the actual date

basis

Term I

Term 2 G pt for items

Te rm3 If at any time documents submitted/



cancelled,

Supply to be made direcUy.Term 4

Term 1 6(six) week (of the actual date

supply order on FOR Destination

basis

G,ST as applicable will be extra except for items

where.no tax has been approved.

documents submitted/



cancelled.

If at any ttme

Term 2

.: -

Term 3

Term 4 Supply to be made direcfly.

Term 2

Page 10 of 17

Vendor NameREVAT I.ABORATORIES PvT.LTD,

8-2-700, Srida Anushka Pride , Road

No.12, Banjara Hills, Hyderabad -

500 034

Mobile/ Tel No:040-23097936

98q5t215ss /.-.,:'.

Fax No (if any): 0091-040-

23095071


Mobile/ Tel97 22 50457300

Fax No (if any): 9

Email: nernelin

rajenderan.krishnamu

Vendor NameSAI PARENTERALS PvT LTD

Fax No (if any): 0091-040-

23095071


[email protected]

8-2-700, Srida Anushka Pride , Road

No.12, Banjara Hills, Hyderabad -

500 034

Mobile/ Tel No:9885021555 /040-23097936/9848237 737

Term 1 Delivery within 6(six) week (of the actual dateof dispatch) of supply order on FOR Destination

basis



,It:"submitted/

the tender is

award will be

f

ca

**,1 Supply to be made directly.

the actual date

R Destination

submitted/

award will be



basis

. Term 2 GST aiapplicable'will be extra except for items

where no Ex has bd4r approved.



cancelled.

Supply to be made directly.Term 4

Page 1l of 17

Vendor NameRoche Products (India) Pvt.Ltd.

146-8, 166 A, Unit No. 7,8,9,8thFloor, R City Office, R City Mall

Lal Bahadur Shastri Marg,Ghatkopar,

Mumbai - 400 086

Term 1



3Term

ths firm in the tender is

If at

candelled.

4Term Supp[l to be niade directly.

na,

Vendor NameSanofi - Synthelabo (India)Private Limited

Sanofi House, C.T.S No.117-B, L&T

Business Park, Saki Vihar Road,

Powai, Mumbai - 400 072

Mobile/ Tel No: 9312403063 /916790s0091 022

Fax No (if any): 02

EmaiI institution.busin

[email protected]

vendor NameSANOFI INDIA LI

Sanofi House, C.T.

T Business Parl!Powai, Mumbai -

Vendor NameSERDIAPHARMACEUTICAL(INDIA)PvT.LTD

1703, 17th Floor, Parinee Crescenzo,

'B' Wing, Plot Nos. C 38 & 39, 'G"Block, Behind MCA, Bandra Kuila .i'

Complex, Bandra (East), Mumbai -400051.

Mobile/ Tel No: 9449068957 /022 - 68100700

9

,com



basis





.found to be false/ erroneous. the award will be

iancelled. ' 'Term 4 Supplv'to be made directly.

eeks (of the actual date

rder on FOR Destination

tra except

oved.for items

submitted/the tender is

award will be

order on FOR Destinationks (of the actual date


wlidre no-tatrhe biieh approved,

If at any time documents submitted/



cancelled.

Term 3


Page 12 of 17

Mobile/ Tel No:9312403063 /9167905009/ 022 28032000

Fax No (if any): 022 28032939


institution.business@sanofi .com

Fax No (if any):Emai!: [email protected]

[email protected]

0i20

1Term

Term 2

Term 3

cancelled.

Term 4 Supply to be made directly;

Term 1

Vendor NameSIGNATURE PHYTOCHEMICAL

INDUSTRIES

310, 3rd Floor T.V Industrial Estate

S.K Ahire Marg Worli Mumbai 30

Mobile/ Tel No: 9930212908 /022-66261400

Fax No (if any): 022-66241.41


[email protected]

Vendor NameSUN PHARMA LABORATORIES

LIMITED

Sun House, 201 B/1, Western

Express Highway, Goregaon East,

Mumbai - 400063

Mobile/ Tel No:9819319102 /022 4324 4324

Fax No (if any): 022 4324 4343

Email:hemantakumar,[email protected]

Fax No (if any): 044 - 28589090




basis



If at any time documents submitted/information given by the firm in the tender is


cancelled.


Term 1 Delivery n 6(six) weeks (of the actual date

of dis

basis

of supply order on FOR Destination



Term 3 if at any time documents submitted/



cancelled.

Term 4 Supply to be made direcdy.

Term I





found to be fulse/ erroneous, the award will be

cancelled.


Page 13 of 17

\

J(

Vendor NameTABLETS (INDIA) LIMITED

# 72, Marshalls Road, "Jhaver

Centre" R A Building, 4th Floor,

Egmore, Chennai - 600 008 '

Mobile/ Tel No:9600152152 /0zl4 - 42050186

()

Term 3

r)l

Term 2



basis

t

lU 12,Udyog Naga r,S.V. Road,

Goregaon(W),M umbai-400 104

Mobile/ Tel No:9022951026 /91-22-67607080

Fax No (ifany): g!-22:'. , i6760707012874662t


Vendor NameTRIOKKA PHARMACEUTICALS

LIMITED

Commerce House-1, Satya Marg,

Bodakdev, Ahmedabad - 380054

Mobile/ Tel No:9879615617 /07 9 -268s6242 I 43 I 44 I 45

Fax No (if any): 079-26856246


[email protected]

Vendor NameUSV PRIVATE TIMITED

Fax No (if any): 022 25584025


[email protected]

Delivery within 6(six) week (of the actual dateof dispatch) of supply order on FOR Destinationbasis

Term 2 GST as applicable will be extra except for itemswhere no tax has been approved.


found to be false/ erroneous, the award will be...ca ncelled .

Term 4

1Term Delivery within

of dispatch) ofbasis

(of the actual date

on FOR Destination

Term 2 GST as applicable will be-e*ra except for items



found to be false/ erroneous/ the award will be

cancelled.

4 Supply to be made directly.

ofispatch

kswee of het ctuaa datetxwith n 6 ) (ry (FOn DeR natisti nou rdero od p lyp


nl.. !.,t9...

approved.Xtawh9.!'e

Teriir 3


cancelled.

If atiriform

ts

mti mdocu nts s bu ittedm

n n het rmfi n ht tender Sati ve by


Page L4 of 17

Vendor NameTHEMIS MEDICARE LIMITED

Arvind Vitthal Gandhi Chowk, B.S.D

Marg, Govandi Station Road,

Mumbai - 400088

Mobile/ Tel No:9004084309 /987 159 49 46 I 022 255 64048

Term 1

Term 1

Plot No. 319 & 320, 3rd

FloorSwamyAyyappa Co-op. Housing

Society, Madhapur, Hyderabad 500

081

Mobile/ Tel Nor

8879110909/097000u€?0 /+91-40-23119481

+91-40-23119486

Fax No (if any): Fax No:

23119486.


sham [email protected]

Vendor NameWINDI.AS BIOTECH PRIVATE

LIMITED

7 05-706, Vatika Professional point,

sector-66 golf course ext, road,

Gurgaon-122001 Haryana

Mobile/ Tel No:9555823672 /t24-2821030



basis





the award will beeolltel erbe.fals

nci:lled

.a,

ufo dn to ron

ca

Term 4 Supply to be made directly

actual datery withinDestinationdispatch) ofof

basis

'Term 1

pt for itemsterm z

ca

submitted/the tender is

award will be

.ate firm tnnformation g

thebe fa

mdocunatIhMen

tondfou se/

Term 3

Term 4

term I

basis

6(six dI ateks fo het cta uaWC) (

nDeR onatistirdero no FOUsd pp ly

Term 2 GST as applicable

where no tax has

be extra except for items

approved.

will



If at documents submitted/mea

cancelled

'-Term 3

Supply to be made directlY.Term 4

Page 15 of 17

Vendor NameVIRCHOW BIIOTECH PvT LTD

Vendor NameWALLACE PHARMACEUTICATS

PVT. LTD

A 303/312 Floral Deck Plaza; Off

Central MIDC Road, Andheri (East),

Mumbai-400093

Mobile/ Tel No:

9820360019i981112970t I022-68311100

Fax No (if any): 022'28390733

Email: p;[email protected]

[email protected]

ms379@hotmail,com

Fax No (if any): 124-2821060

Email:[email protected]

GST as applicable willwhere no tax has been approved.


Delivery within

&a

7215 Muradpura(OrangPura) Dhar

Road Near Kalaria Indore M.P. Pin

453001

Mobile/ Tel No: 8435501868 /843s501867

Fax No (if any): 073L-2435123

Emaili [email protected]

Vendor NameZUVENTUS HEALTHCARE

LIMITED

Vendor NameZim Laboratories Limited


/9823089 1 2sl 07 118-27 147 0 | 480

Emaill [email protected]'

[email protected]. ka ma I *6zim lab. i n

Office No. 5119, 5th Floor, D Wing

Oberoi Garden Estates, Chandivali;

Andheri (E), Mumbai 400 072.

Mobile/ Tel No: 9820511787 /022 3061 0000

Fax No (if any): 022 2847 2829

Emai!: [email protected]

[email protected]

Term 1


where no tax has been approved.Term 2



el er uglr*, waa rd II beeronls thfo nu tod be

cen ledIca

made.d rectyu be5 p

Delivery within

of dispatch) ofbasis

6(six) weeks (of the actual date

supply order on FOR Destination

GST

whe

except for itemsas ap ip

found to be

cancelled,

neous, the award will be

in thIf ti

by

submitted/e tender isinformation

false/ erro

3

Supply to be mTerm 4

ks (of the actual dates weenDelive 6(rynoFOn tiDesti naRu rdeo oIp lyp

Term 2 GST as a

whele 1o

pplicable will be extra except for items

tax'has been approved.

Term 3 documents submitted/If at any time

cancelled.

Supply to be made directlY.

Page 15 of 17

Vendor NameZENITH DRUG PvT LTD

B-2U27, MIDC Area, Kalmeshwar-

441501 Dist. Nagpur



basis

Term 1

Term 2

basis

1



Term 4

Vendor NameZYDUS HEALTHCARE UMITED

Scheme No. 63, Survey No. 536,

Khoraj (Gandhinagar), S,G.

Highway, Nr. Vaishnodevi Circle,

Ahmedabad-382481

Mobile/ Tel Nor 98

079-26868100

11303727 I

Fax No (if any)r 079-26868100




basis



Teim 3 submitted/the tender is

award will be

fi

be

cancelled.


Page L7 ol L7

Index 143C

SNo ItemNo.

Page

no

I 33

Bronchodilator Syp-

Each 5ml to contain: Theopyllin Ethanoate Of Piperazine 80m9,

Eph. Hcl.12mg, Guaiphenesin 50m9, Alcohol 0.55m1, Absolute

Alcohol Content 10.44 o/o. 1

z 60

Frusemide Tab/Gp-Each Tab/Gp to contain: Frusemide 40mg 1

3

Isoxsuprine Inj-Each ml to contain: Isoxsuprine 5mg 1

4 7tHeparin Sodium Inj-Each ml to contain: Heparin Sod. 5000 IU 1

5 75

Flunarizine Tab/Gp-Each Tab/Cap to contain: Flunarizine 10mg 7

6 97

Fluoxetine Tab/Cap-

Each Tab/Gp to contain: Fluoxetine 20mg 7

7 98

Phenytoin Sodium Tab/Cap-

Each Tab/Cap to contain: Phenytoin Sodium 100ms 2

I 103

Trihexyphenidyl Tab/Cap-

Each Tab/Gp to contain: Trihexyphenidyl Hydrochloride 2mg 3

9 362Budesonide Inhaler-Each Metered Dose to contain : Budesonide 100 mcg 3

10 365

Losartan+Hydrochlorthiazide Tab/Cap-

Each Tab/Cap to contain: Losartan Potassium

Hydrochlofthiazide 12.5 mg

50 mg,

3

367

Fenoflbrate Tab/cap-

Each Tab/Cap to contain: Fenofibrate ( Micronised ) 200 mg 4

421

Ipratropium + Salbutamol Inhaler-

Each l4etered Dose to contain: Ipratropium

Salbutamol LP. ioomcg

I.P.20mcA.,4

422

Amiodarone Tab/Gp-Each Tab/Cap to contain: Amiodarone Hcl 1Qomg 4

L4

Indapamide SR Tab/Gp-Each SR Tab/Cap to contain : Indapamide 1.5 mg

15 429Clopidogrel Tab/Cap-

Each Tab/Cap to contain: Clopidogrel 75mg

47tfianeptine Tab/Cap-

Each Tab/Cap to contain: Tianept ine Sodium 12.5m9 5

17

Ipratropium Resp. Soln-

Each ml to contain:I ratro um Bromide 250 m 6

516

Etophylline & Theophylline Syp-

Each 5 ml to contain: h line 45.5 Theo lline 14m 6

i9 518

Cough Sedative Syp-

Each 5ml to contain: Chlorpheniramine Meleate 2.5m9,

Guai enesin 100 Nosca ine 15m Sodium Citrate 60 m 6

20 521

Tranexamic Acid Tab/Cap-

Each Tab Ca to contain: Tranexamic Acid 500m 7

21 s22Tranexamic Acid Inj-Each 5ml to contain: Tranexamic Acid 500m 7

5

Page 1of 8

Item Description

63

II

11

12

13

425

I

ls

16

481

18

I

Index 143C

SNo ItemNo.

Item Description Page

no

22 540

Sulbutiamine Tab/Gp-Each Tab/Gp to contain: Sulbutiamine 200m9 7

23 550

Fluticasone+Salmetrol Rotacap-

Each Rotacap to contain: Fluticasone 250 mca, Salmetrol 50

mcg 8

24 574

Metoprolol Inj-Each ml to contain: Metoprolol 1mg 8

25 580

Coagulant Solution-Each ml to contain: Aqueous Solution Of Haemocoagulase

Isolated From Bothrops Atrox Or Bothrops lararaca 0.2CU,

Chlorhexadine Gluconate Soln.0. lpercent (As Preservative),Water For Inject i9n Q.s I

26 1032

Etophylline & Theophylline Tab/Cap-Each Tab/Cap to colltain: Etophylline 77 mg,Theophylline 23 mg 9

27 1041

Salbutamol + Beclomethasone Inhaler-Each Metered Dose to contain: Salbutamol 100 mcg.,Beclomethasone Di onate 50 mcg. 9

28 1050

Pediatric Cough Linctus Syp -

Each ml to contain : Noscapine 1.83m9, Citric Acid 5.8m9, Sod

Citrate 0.67m9, Amm . Chloride 7mg 9

29 1055

Bisoprolol Tab/Cap-Each Tab/Cap to conta in: Bisoprolol Fumerate 5 mg 10

30 1063

Trimetazidine Ta b/Cap-Each Jeblcap to contain: Trimetazidine Hcl 20 mg 10

31 1074Isoxsuprine Tab/Cap-Each Tab/Gp to contain: Isoxsuprine Hcl 10 mg 10

32 1078

Haemo-Coagulant Inj-Each ml to contaln : Aqueous Solution Of Haemocoagulase (OneI U/CU/NIH Unit) Isolated From Venom Of Bothrops, JararacaOr Bothrops Atrox Containing Sodium Chloride 0,9% 10

33

Nimodipine Tab/Cap-Each Tab/Cap to contain : Nimodipine 30 mg 11

34 1131

Sodium Valproate Tab/Cap -Each Tab/Gp to contain: Sodium Valproate 200mq. 11

2( tt32Levodopa & Grbidopa Tabi Gp-Each Tab/Cap to contain: Levodo pa 250 mg, Grbidopa 25 mq 72

36 1348

Valsartan Tab/Gp-Each Tab c.a to contain: Valsartan 72

37 1349

l,letolazone Tab/Cap-Each Ta Cap to contain Metolazone 5mg tz

38 1370 Each Tab Ca to contain: Torsemide 10m 13

39 t372 13

40 1393

Mefenamic + Tranexamic Acid Tab/Cap-Each Tab/Gp to contain: Mefenamic Acid 250m9, TranexamicAcid 500 13

t724

Torsemide Tab/Gp-

Perindopril + Indapamide Tab/Cap-Each Tab/Cap to contain: Perindopril Erbumine 4mg,Indapamide 1.25mq

PaBe 2 of 8

SNo ItemNo.


no

4t t420Telmisartan Tab/Cap-

Each Tab/Gp to contain: Telmisartan 40mg 74

47 14ZlPerindopril + Amlodipine Tab/Cap-

Each Tab/Cap to contain: Perindropil 4mg, Amlodipine 5mq

43 1461

Hydroxyzine Hydrochloride Tab/Cap-Each Tab/Gp to contain: Hydroxyzine Hydrochloride 25mq I4

44 1.522

Inhaler -

Each Metered Dose to contain: Ipratropium l:}mq,Levosalbutamol 50mcg 15

45 t524Budesonide Respule-

Each 2ml to contain Budesonide 1mg Steriod Nebulizing Fluid 15

1525

llotropium Bromide Rotacap-

Each Rotacap to contain :'Iiotropium Bromide IPIBP Eqv. to'1-iotro ium Bromide Monoh rate 18mcg.

47 1530

lvabradine Tab/Cap-

Each Tab/Cap to contain: Ivabradine 5mg

48 1668

Olmesartan Tab/Cap-

Each Tab/Cap to contain : Olmesartan 20mg 77

49

Haemostatic-

Each 5ml to contain: Haemostatic Matrix With Prefilled GelatinGranules In Syringes 17

50 7674Sumatriptan Tab/c.ap-Each Tab/Cap to contain: Sumatriptan 50mg 18

51

Citicoline Tab/Cap-Each Tab/Cap to contain: Citicoline 500 mg

52 1682

Divalproex Sod. Tab/Cap-Each SR/ER/CR Tab/Cap to contain: Divalproex Sod. 250mq 19

53

Divalproex Sod. Tab/Cap-

Each SR/ER/CR Tab/Gp to contain: Divalproex Sod. 500mq 19

54

Inhaler-7749 Each Metered Dose to contain: Levosalbutamol Tartrate 50mcg 70

1751

Nebivolol Tab/Cap-Each Tab/Cap to contain: Nebivolol 5mg zo

56 1752

Tenecteplase 40mg Inj-Each Vial to contain: Tenecteplase 40mg 20

57 1754

Indapamide SR + Amlodipine Tab/Gp-Each Tab/Gp to contain: Tab/Gp Indapamide SR 1.5 mg,Amlodipine Besylate Equivalent To Amlodipine 5 mg

58 1840

Inhaler-

Each Delivered Dose to contain: Salmetrol Xinafoate IP

Equivalent to Salmetrol IP 25 trg, Fluticasone Propionate IP

250p9, Excipients & Propellant 1, 1,1.2 Tetrafluoro Ethane HFA

134a

Autohaler-

Each Delivered Dose Of Autohaler to contain: Salmeterol (As

Salmeterol Xinafoate) IP 25 mcg, Fluticasone Propionate IP

250mcA Suspended In Propellant 134a Q.S. (Contains AbsoluteAlcohol Ip 5olo v/v) 2t

Index 143C

l4

16

2t

2l

59

Page 3 of 8

z*b 16

1670

1681 18

1683

55

1843

I

I

77

75 2067

Index 143C

Metoprolol Succinate SR Tab/Gp-Each SR Tab/Cap to contain: Metoprolol Succinate 23.75m9

uivalent To Meto rolol Tartrate 25m 22

7?

25

26

SNo Item Description

no

60

1869 22

62 1870

Amisulpride Tab/Gp-Each Tab/Cap to contain: Amisul

Each Tab/Cap to contain Quetiapine 25 mg

pride 50mg

Quetiapine Tab/Cap-

1871Quetiapine Tab/Cap-

Qp to contain: Quetiapine 100 mgEach Ta 2363

1873

Paroxetine CR Tab/Gp-Each CR Tab/Cap to contain: Paroxetine 25mI

65I Levetiracetam Tab/Cap-

p to contain: Levetiracetam 500mq1879 I Each Tab/Ca 24

66 1880

Levetiracetam Tab/Cap-

to contain: Levetiracetam 250Each Tab ca 24

67 1883 25

68 20t4 to contain: Montelukast Sodium 10m

Each Ta ine 100mG to contain: Lamotr

Each Ta G

Lamotrigine Tab/Cap-

Montelukast Sodium Tab/cap-

69 2015

Beclomethasone Dipropionate IP 200mcg (HFA Technology)Inhaler-

Each I'4etered Dose to contain: Beclomethasone Dipropionate Ip2Q0mcg (HFA Technology)

70 20t9

Indapamide (As SR)1.5m9 , Amlodipine B€silate Equivalent toAmlodipine 2.5m9, Excepients QS Film Coated Bi-LayeredTab/Cap-

Each Film Coated Bi-Layered Tab/Cap Contains: Indapamide (As

SR)1.5m9 , Amlodipine Besilate EquvalentTo Amlodipine 2.5mg,Excepients QS

Acenocoumarol / Nicoumalone Tab/Cap-Each Tab/Cap to contain: Acenocoumarol / Nicoumalone 2mq 26

2060

Ambroxol + Terbutaline Tab/Gp-Each Uncoated Tab/Gp to contain; Ambroxol Hrdrochloride 30

Terbutaline Sul hate uivalent to Terbutaline 2,5 26

2061

Ambroxol + Terbutaline Syp-

Each 5 ml to contain: Ambroxol Hrdrochloride IP 30 mg,Terbutaline Sulphate IP Equivalent to Terbutaline 2.50 mg,Guaiphenesin IP !0 49, Menthol IP 0.5 mg

74

Inhaler-

Each Inhaler to contain: Fluticasone Propionate 250mcg,Formoterol Fumarate 6m

76 2068

S(-)Metoprolol TabiCap-Each CR/PR/DR/SR/MR Tayc;,p to contain : S(-)Metoprotot

.toS rolol Tartrate 25MetoSuccinate 23.75 m

50m

z8

Page 4 of 8

ItemNo.

Page

1845

b1

64 23

I

2063

SC)Metoprolol Tab/Cap-Each Prolonged Release Film Coated Tab/Gp to contain : S(-

)Metoprolol Succinate 47.50 mg Eqv. to S(-) Metoprolol Tartrate

25

I

2022

73

Index 143C

SNo Item Description Page

no

77 2069Tlcagrelor Tab/Cap-Each Tab/Cap to contain:Ticagrelor 90mg 28

2070

Ivabradine Tab/Cap-

Each Film Coated Tab/Cap to contain: Ivabradine Hcl Equivalent

To IvabradineT.5mq 28

79 2074

Indapamide + Amlodipine Tab/Gp-Each Film Coated Bilayered Tab/Cap to contain Indapamide (As

Sustained Release) 1.5m9 and Amlodipine Besilate Equivalent toAmlodipine 10mg 28

80 7076

Micronised - Purified Flavonoid Tablcap-Each Film Coated Tab/Cap to contain: Micronised - Purified

Flavonoid Fraction 1000m9-Composed Of Diosmin 900m9(90o/o) And Flavonoids Expressed As Hesperidin 100mq (100/o) 29

81 2077

Hemostat-

Each PFS to contain: Hemostatic Matrix With Thrombin InPrifilled Syringe 10ml

82 2078

Apixaban Tab/Gp-Each Film Coated Tab/Gp to contain: Apixaban 2.5mq 29

83 2079Apixaban Tab/cap-Each Film Coated Tab/Gp to contain: Apixaban 5mq 30

84 2080

Dabigatran Tab/Cap-

Each p to contain: Dabigatran Etexilate 110 mg 30

85 2081

Anticoagulants-

Each Kit to contain:Two Componant Fibrin Sealant WithSylthetic Aprotinin (4ml) 31

86 2203

Terbutaline + Guiaphenesin + Ambroxol Syp-

Each 5 ml to contain: Terbutaline I.P 1.25m9 + Guiaphenesin

I.P + Ambroxol I.P 15mg Syrup Base QS 31

87 2204

Dextromethorphan + CPM Syp-

Each 5 ml to contain: Dextromethorphan I.P 10mg +Chlorpheniramine l4aleate I.P 2mg Syrup Base QS 37

88 2205

Ibutilide-Each ml to contain: Ibutilide Fumarate 0.1m9 ( Equivalent ToIbutilide Freebase 0.087m9), Water For injection 32

89 2207

Glyceryl Trinitrate Spray-

Each Metered Dose to contain: Glyceryl Trinitrate Spray -0.4 Mq ?1

90 2208

Human Albumin-

Each Bott to contain- Human Albumin 25o/o 100 ml In Flexible,

Self Collapsible- Closed System Baqs 33

91 2209

Emicizumab Inj-Each Vial Contains : Emicizumab 30mg For Sub Cut Injection (R-

DNA Oriqin) 33

92 22l0

Emicizumab Inj-Each Vial Contains : Emicizumab 60mg For Sub Cut Injection (R-

DNA Oriqin) 33

Page 5 of 8

ItemNo.

78

29

Index 143C

SNo ItemNo.


no

93 22tt

Micronized - Purified Flavonoid Tab/Cap-

Each Film Coated Tab/Cap to contain : Micronized - Purified

Flavonoid Fraction 500m9 Composed Of Diosmin 450m9 (90%)

And Flavonoids Expressed As Hesperidine 50mq (10o/o) J.i

94 2299

Telmisartan Tab/Cap:

Each Tab/Cap to contain: Telmisartan 20mg 34

95 2302Dabigatran Etexilate Tab/Cap-

E.in"i.ulc"E" ilnt"nl OJuiqutran Etexitate lsomq 51

q6 2303

Acetyl Sdlicylic Acid + Atorvastatin Tqblcap-Each TdblGD to contaih: ACetyl Salicylic Acid 75m9,Atorvastatin 20mq 35

97 2306

Diltiazem CR/ SR/ DR/ tvlR Tab/Gp-Each CR/ SR/ DR/ MR Tab/Cap to contain: Diltiazem 90mq 35

98 2309

Codein Lint. Syp/Susp-

Each sml to contain: Chlorpheniramine Maleate 4mg, Codeine

Phosphate 1omg 3s

99 2312ftriptyline

Gabapentin + Nortriptyline Tab/Cap-

Each Tab/Cap to contain: Gabapentin

10mg

100m9, No

36

100 2377

balin Tab/Cap-PLAIN/SR/CR/DR/ER/MR Tab/Cap to contain: Pregabalin

Prega

Each

75 36

101

Beclomethasone Inhaler-Each Metered Dose to contain: Beclomethasone Dipropionate100mcg. 36

102 1043a

Salbutamol Rotacap-

Each Rotacap to contain : Salbutamol 200mcg

103 1056a

Metoprolol Tab/Cap-

Each Tab/Gp to contain: 37

104 1060a

Iso-Sorbide Mononitrate Tab/ p-

Each Tab/Cap to contain: Iso-Sorbide-S-Mononitrate 20 mg 37

1067b

Prazosin SR Tab/Cap-

Each SR Tab/Gp to contain: Prazosin Hcl 2.5 mg

106 1067c

Prazosin SR Tabicap-Each SR Tab/Cap to contain: Prazosin Hcl 5mg 38

\07 1068b

Ramipril Tab/ Cap-

Each Tab/ Cap to contain: Ramipril 2.smq 39

108 1068c

Ramipril Tab/Cap; '-

Each Tab/Cap to contain: Ramipril smg 39

109 1115b

Phenobarbitone Tab/Gp-Each Tab/Cap to contain: Phenobarbitone-30m9 40

110 1727 a

Carbamazepin CR Tab/Cap-

Each CR Tab/Cap to contain: Carbamazepin 200m9 40

111 1370b

Torsemide Tab/Cap-Each Tab/Cap to contain: Torsemide 20mq 40

Page 5 of I

1040b

105 38

Index 143C

SNo ItemNo.


no

tt7 1430b

Mirtazapine Tab/Cap-

Each Tab/Cap to contaln: Mirtazapine 15mg 47

113 324a

Clobazam Tab/Cap-

Each Tab/Cap to contain: Clobazam 5 mg 47

t14 324b

Clobazam Tab/Cap-

Each Tab/Cap to contain: Clobazam LP.10 mq 41

32bEach ml to contain: Salbutamol Sulphate Eqv. to Salbutam

mg. In Normal Saline Soln.

ol 542

116 336b

Grvedilol Tab/Cap-

Each Tab/Cap to contain: Carvedilol 6.25m9

117 366a

Enoxaprin Inj-Each PFS to contain Enoxaprin Sodium 20 mg / 0.2 ml.

118 366c

Enoxaparin 60 mg/0.6m1 Inj-Each PFS to contain: Enoxaparin 60 mg/0.6m1 43

119 420a

Fluticasone + Salmeterol Inhaler-Each Metered Dose to contain: Salmeterol

50mcg

25mcg, Fluticasone

43

t20 423aNicorandil TablCap-Each Tab/Cap to contain: Nicorandil 5mg 43

72t 433b 44

722 44b

Propranolol Tab,/ Ca

in: Propranolol 40mg

p-

Each conta 44

tz3 470aPerindopril Tab/Cap-Each Tab/Cap to contain: Perindopril 2mq 44

t74 470cPerindopril Tab/Cap-

Each Tab/Cap to contain: Perindopril Erbumine 8mg 45

125 473aResperidone Tab/cap-Each Tab/Cap to contain: Resperidone 1mq 45

726 474bOlanzapine Tab/Cap-Each Tab/Cap to contain: Olanzapine 5mg 45

727 475bHaloperidol Tab/Cap-

Each Tab/Cap to contain: Haloperidol 5mg 46

128 477 a

Amitriptyline Tab/Gp-Each Tab/Cap to contain: Amitriptyline 10mg

LZg 477bAmitriptyllne Tab/Cap.

25mqEach Tab/Cap to contain: Amitriptyline 46

130 486a

Paroxetine Tab/Gp-Each Tab/Cap to contaln: Paroxetine 1Omg 46

131 486b

Paroxetine Tab/Cap-

Each Tab/Cap to contain: Paroxetine 20mg

525a

I4etoprolol ER Tab/Gp-Each ER Tab/Cap to contain: Metoprolol Succinate 47.5m9

Equivalent to Metoprolol Tartrate 50mq. 47

133 527a

Gabapentin Tab/Cap-

Each Tab/Cap to contain: Gabapentin 300m9

Page 7 of 8

115

42

42

Sodium Valproate + Valproic Acid CR Tab/Cap-Each CR Tab/Cap to contaln: (Sodium Valproate + Valproic Acid)Eqv. to Sodium 500mq.

46

47

132

48

aEl

r-

Index 143C

SNo ItemNo.


no

734 555a

Clozapine Tab/Cap-Each Tab/Cap to contain : Clozapine 25mg 48

135 555b

Clozapine Tab/Cap-

Each Tab/Gp to contain: Clozapine 100m9 48

136 556a

Escitalopram Tab/cap-Tab/Gp to contain: Escitalopram 10 mqEach 49

737 556b : Escitalopram 20 mq 49

138 557aDalteparin Sodium Inj-Each PFS to contain: Dalteparin Sodium 2500 IU Units 49

139 557b

Inj-5000 IU UnitsnEach PFS to

Dalteparin

50

140 68a 50

141 74a 50

Page I of 8

Sodium

Ethamsylate Tab/Crp-Each Tab/Cap to contain Ethamsylate 250 mqStreptokinase Inj-Each Vial to contain: Streptokinase I.P 7.5 Lac IU

Employes' StaE fnsurance Corporation

Rate Schedule of Running Rate Contract No. U-25/12lf42C-L46C|zOLg-Med V FOR RC 143C

Valid from Thursdan October 14U, 2O2L to Tuesday, October 315t 2023

PackingDrug Description

Firm Name Firm Rate/unit Packing

Preference De*ription of stores ac@pted

200m1 Bottle33 Bronchodilator Syp-

Each 5ml to contain:

Theopyllin Ethanoate Of Piperazine 80m9,

Eph. Hcl.12mg, Guaiphenesin 50m9,

Alcohol 0.55mlt'Absolute Alcohol Contqn!.!q419lo.:

HindustanLaboratoriesLimited

Juggat Pharma(Pharma DivisionOf Jagdalelndustries PrivateLimited)

Sai Parenterals Pvt.Ltd.

0.36 Per 10 Tabsl Tab/Cap

47.24 HIPH E

200m1 Bott SAME AS I

Rupees Forty seven AND Paise Two Four Only

ITEM200 mlBottle.,

R

Rupees Nil AND Paise Three Six Only

63 Isoxsuprine Inj- 2ml Vial/Amp

Each ml to contain: Isoxsuprine smg

2ml Amp FIRST TIDITAN9.00 Per2ml ViaUAmp IN ITEM

Rupees Nine Only

77 Heparin Sodium Inj-Each ml to contain: Heparin Sod.5000 IU

5ml Vial/Amp

FIRST SAME AS IN ITEM195.O0 Per l Vialsml ViaUAmp

Rupees One Hundred Ninety Five Only J_.^--*/-

Page 1 of 50

ftem No

MicronPharmaceuticals

FIRST

60 Frusemide Tab/Cap-

Each Tab/Cap to contain: Frusemide 40mg

1 Tab/Cap

Em ptoy@s' State fnsuran@ Corporation

Rate Schedule of Running Rate contract No. U-25/121142C-L46C12OL9-Med V FOR RC 143C

Valid from Thursday, October 14th 2021 to Tuesday, October 31"t 2023

ftem No

aceptedPreferenceFirm Rate,/unit

Firm Name

75 Flunarizine Tab/CaP-

Each Tab/Cap to conta in: Flunarizine 10mq

FDC Limited

Fluoxetine Tab/CaP-

Each Tab/Cap to contain: Fluoxetine 20mg

0.39 Perl Tab/Cap

0.58 Perl Tab/Cap

1.50 Perl Tab/Cap

o.30 Perl Tab/Cap

0.36 Perl Tab/Cap

0.41 Perl Tab/Cap

10Tabs FIRST

10 TabS FIRST

10 Tabs

120 Tabs THIRD

Revat LaboratoriesPvt. Ltd.

Zydus HealthcareLtd

Abbott IndiaLimited

Rupe Nil AND Paise FiYe Eight OnlYo

Rupees One AND Paise Six Zeru OnlY

98 Phenytoin Sodium Tab/CaP-

Each Tab/Cap to contain: Phenytoin Sodium 100m9

l Tab/Cap

10 Tabs FIRST SAME AS IN ITEM

Rupees Nil AND PaiseThre Six OnlY

SECOND FLOATIN 20 MG

SAME AS IN ITEt"l

EPTOINSAME AS IN ITEM

Rupe Nil AND Paise Thre Zerc OnlY

looTabs SECOND EPSOUNSAME AS IN ITEM

Rupees Nil AND Paise Four One Onl2

Page 2 of 50

FirmPackino

De*ription of storcs

HabPharmaceuticals &Research Ltd

MesmerPharmaceuticals

FLUNARIN 10 MG

SAME AS IN ITEM

t

Rupees Nit AND Paise Three Nine Only

97 1 Tab/Cap

ELEVAT

SAME AS Iil ITEM

t.

Druo

1 Tab/Cap

Em ployees' State fnsura nce Corporation

Rate Schedule of Running Rate Contract No. U-25/12l142C-L46C|2OL9-Med V FOR RC 143C

Vafid from Thursday, October L4tj 2O2L to Tuesday, October 31't 2023

ftem No Drug Description Packing

Firm Name Firm RaE/unit Packing

Prefercnce

103 Trihexyphenidyl Tab/Cap-

Each Tab/Cap to contain:Trihexyphenidyl Hydrochloride 2mg

1 Tab/Cap

362 Budesonide Inhaler-

Each Metered Dose to contain :

Budesonide 100 mcg

Equal to or more than 120 MDI

2OO MDT FIRST BUDECORT 1OO CFC FREE INH(WITH DOSE COUNTER)

SAME AS IN ITEM

Ru6es Nil AIVD Paise Thrce Five Only


Midas CarePharmaceuticals

Pvt. Ltd.


O.72Per1 Tab/Cap

0.84 Perl Tab/Cap

0.35 Perdose

Rupees Nil AND Paise Three Six Only

l0Tabs FIRST LOSARK-H

SAME AS IN ITEM

MacleodsPharmac€uticalsLimited

Rupees Nil AllD Paise Eight Four Only

15 Tabs SECOND OMNTTAN HSAME AS IN ITEM

365 Losartan+Hydrochlorthiazide Tab/Cap-Each Tab/Cap to contain:Losartan Potassium 50 mg,Hydrochlorthiazide 12.5 mq

1 Tab/Cap

Page 3 of 50

Dexription of stores acepted


Rupees Nil AND Paise Seven Two Only

Cipla Limated

0.36 Per 240 MDI SECOND BUDESONE 1OO INHATATIONdOse SAMEASIN ITEM

1.07 Perl Tab/Cap

Rupees One AND Paise Zero Seven Only

/1*u

Employees' State fnsurance Corporation

Rate Schedute of Running Rate Contract No. U-25/12l142C-l46Cl20l9-Med V FOR RC 143C

Valid from Thursday, October 1#h 2021 to Tuesday, october 31't 2023

Packinqftum No Drug Description


De*ription of s'tores ac@pbd

367 Fenofibrate TabiCap-

Each Tab/Cap to contaln:

Fenofibrate ( Micronised ) 200 mg

1 Tab/Cap


SignaturePhytochemicallndustries

1.80 Perl Tab/Cap

0.90 Perdose

2.40 Perl Tab/Cap


Rupees One AND Paise Eight Zero Only

USV Private Limited 2.68 Per Strips of SECOND UPICARD 20OMG

l Tab/Cap 10 Caps SAME AS IN ITEM

Ipratropium + Salbutamol Inhaler-

Each Metered Dose to contain:

Ipratropium I.P.20mcg., Salbutamol I.P.100mcg


240 MDI FIRST SAUPRAIR HFA INHALATIONSAME AS IN ITEM

Rupees Nil AND Paise Nine Zero Only

Amiodarone Tab/Cap-

Each Tab/Cap to contain: Amiodarone Hcl 100m9

1 Tab/Cap


Rupees Two AND Paise Four Zeru Onlln

Page 4 of 50

Preference

Rupees Two AND Paise Six Eight Only

42t

Midas CarePharmaceuticalsPvt. Ltd.

422

Em ployees' State fnsurance Corporation

Rate Schedule of Running Rate Contract No. U-25l12l142C-L46C|zOL9-Med V FOR RC 143C

Valid from Thursday, October L4th 2O2L to Tuesday, October 31"t 2023



Prefercnce Description of storcs ac@pted

425 Indapamide SR Tab/Cap-

Each SR Tab/Cap to contain : Indapamide 1.5 mg

1 Tab/Cap

Modi MundipharmaPrivate Limited

2.5O PerI Tab/Cap

10 Tabs FIRST INDICONTINSAME AS IN ITEM

Ruryes lwo AND Paise Five Zeto Only

5.90 Per 10 Tabs SECOND NATRILIX SRl Tab/Cap SAME AS tN ITEM

429 Clopidogrel Tab/Cap-Each Tab/Cap to contain: Clopidogrel 75mq

1 Tab/Cap

PulsePharmaceutical ArtLtd

lark Laboratories(India) Ltd.

Themis MedicareLimited

SerdiaPharmaceuticals(India) PrivateLimited

O.72Perl Tab/Cap

4.77 Perl Tab/Cap

10 Tabs FIRST

10 Tabs FIRST STABLONSAME AS IN ITEM

Rupees Nil AND Paise Seven Two Only

CTOTREL 75SAME AS IN ITEM

Rupees Nil AND Paise Seven Eight Only

0.82 Per 10 Tabs THIRD THEMIGRETl Tab/Cap SAME AS IN ITEM

Rupees Nil AND Paise Eight TWo Only

47t Tianeptine Tab/Cap-

Each Tab/Cap to contain:

lianeptine Sodium 12.5m9

l Tab/Cap

Ru$es Four AND Paise Seven *ven Only

Page 5 of 50

SerdiaPharmaceuticals(tndia) PrivateLimited

Rupees Five AND Paise Nine Zeto Only

0.78 Per 10 Tabs SECOilD CLOPILARl Tab/Cap SAME AS IN ITEM

f*',*

Employes' State fnsurance Corporation

Rate Schedule of Running Rate Contract No. U-25/121142C-t46Clz0l9-Med V FOR RC 143C

Valid from Thursdan October l4th 2O2L to Tuesday, October 31.t 2023

ftum No Drug Description Packing

Firm Name Firm Rate/unit

FirmPacking

Prefercnce Dexription of stores ac@phd

481 Ipratropium Resp. Soln-

Each ml to contain:Ipratropium Bromide 250 mcg

15ml Eottle

Cipla Limated

RuBes Fouften AND Paise Nine Zeru Only

Etophylline & Theophylline Syp-Each 5 ml to contain:Etophylline 46.5m9. , Theophylline 14mg

100m1 Bottle

14.90 Per15ml Bott

14.40 Per100m1 Bott

33.74 Per100m1 Bott

15mlBottle

100m1Bottle

100m1

Bottle

FIRST

FIRST

FIRST

Rupes Fourten AND Paise Four Zero Only

IPRAVENT RESPIRATOR SOI.SAME AS IN ITEM

DUOLLINSAME AS IN ITEM

HIMALEATE

SAME AS IN TTEM

MicronPharmac€uticals


Rupees Thifi Thre AM Paise Seven Four Only

518 Cough Sedative Syp-

Each 5ml to contain:Chlorphen iramine Meleate 2.5m9,Guaiphenesin 100m9, Noscapine 15m9,Sodium Citrate 60 mg.

100m1 Bottle

Page 6 of 50

516

f"ry


Rate Schedule of Running Rate Contract No. U-251 L2l142C-t46ClzOL9-Med V FOR RC 143C

Valid from Thursday, October L4$ 2O2L to Tuesday, October 31't 2023

Drug Description Packing


Preference Description of sbres ac@pted

52r Tranexamic Acid Tab/Cap-

Each Tab/Cap to contain: Tranexamic Acid 500m9

1 Tab/Cap

1O Tabs FIRST

l Amp FIRST

GYNAEPIL 5OO

SAME AS IN ITEM

GYNAEPILSAME AS IT{ ITEM

Rupees Four AND Paise Six Five Only

6.33 Per 6Tabs SECOND TRENAXAS00l Tab/cap SAMEAS IN ITEM

Psychotropi6 IndiaLimit€d

Rupees Six AND Pai* Thrce Thr* Only

FDC Limited 7.50 Per 10 Tabs THIRD CLIP 500l Tab/Cap SAME AS rN ITEM

Ru@es Seven /lND Paise Five Zerc Only

522 Tranexamic Acid Inj-Each 5ml to contain: Tranexamic Acid 500m9

1 Amp

12.60 Perl Amp

Rupees Twelve AllD Pai* Six Zeto Only

540 Sulbutiamine Tab/Cap-

Each Tab/Cap to contain: Sulbutiamine 200m91 Tab/Cap

12.07 PerI Tab/Cap

Rupees Tweltle AND Pai* Zeto *ven Only,

Page 7 of 50

ftem No

Psychotropics India 4.65 PerLimited l Tab/Cap

MacleodsPharmaceuticalsLimited

10 Tabs FIRST AR,CALION

SAME AS IN ITEM


*<

Employees' State Insu ra nce Corporation

Rate Schedule of Running Rate Contract No. U-25/121142C-l46Cl20l9-Med V FOR RC 143C

Valid from Thurcday, October L4th 2O2L to Tuesday, October 315t 2023

f@m No Drug Description Packing


Prefercnce Dexription of stores accepted

550 Fluticasone+Salmetrol Rotacap-

Each Rotacap to contain: Fluticasone 250 mcg,

Salmetrol 50 mcg

l Rotacap

Cipla Limited 1.02 Per1 Rotacap

30 CapsBottle

FIRST

Zydus HealthcareLtd


Rupees One AND Paie Zero Two Only

Rupees One AND Paie One *ven Only

1.23 Per 30 Caps THIRD FIUTROL 2S01 Rotacap Bottle (HARD GE|-ATIN CAPSULE)

SAME AS IN ITEM

Rupe* One AND Pai* Two Thrce Only

574 Metoprolol IniEach ml to contain: Metoprolol lmg

5ml Vial/Amp

Cipla Limited

Juggat Pharma(Pharma DivisionOf JagdaleIndustries PrivateLimited)

75.50 Per10ml Bott

R Twelve

12.00 PerSml Vial/Amp

5ml Vial/ FIRSTAmp

METOLAR

SAME AS IN ITEM

BOTROCTOT TOPICALSOLUTIONSAME AS IN ITEM

FIRST

Rupes *venty Six AND Pai* Five Zeru Only 7iz o<l-*a-,>l*r.+

/.-

sB0 Coagulant Solution-Each ml to contain: Aqueous Solution OfHaemocoagulase Isolated From Bothrops Atrox OrBothrops Jararaca 0.2CU, Chlorhexadine GluconateSoln.0.lpercent (As Preservative), Water ForInjection Q.S.

10ml Bottle

Page 8 of 50

10mlBottle

SEROFLO 250 ROTACAPSSAlrlE AS IN ITEM

L.l7 Per 30 Caps SECOND FORAIR 250 RESPICAP1 Rotacap Bottle SAME AS IN ITEM

Em ployees' State fnsura nce Corporation

Rate Schedule of Running Rate Contract No. U-25/121142C-L46C|zotg-Med V FOR RC 143C

Valid from Thursday, October L4tn 2O2L to Tuesday, October 313t 2023



De*ription of stores ac@phd

Etophylline & Theophylline TabiCap-Each Tab/Cap to contain:

Etophylline 77 mg,Theophylline 23 mg

MicronPharmac€uticals

Zydus HealthcareLtd


0.45 Perdose

23.21 Per50ml Bott

240 MDI FTRST

FIRST

O.27 Perl Tab/Cap


0.33 Per 30 Tabs SECOND DERIPHYLLINl Tab/Cap SAMEAS IN ITEM

Salbutamol + Beclomethasone Inhaler-Each Metered Dose to contain:Salbutamol 100 mcA.,

Beclomethasone Dipropionate 50 mcq.


Rupees Nil AND Paise Four Slx Only

Pediatric Cough Linctus Syp -

Each ml to contain : Noscapine 1.83m9,Citric Acid 5.8m9, Sod. Citrate 0.67m9,Amm. Chloride 7mg

50ml Bottle

SALBESONE INHALATIONSAME AS IN ITEM

Rupees fwenty Thtce AND Paise Tluo One Only?

Preference

1032 1 Tab/Cap


Rupees Nil AND Paise Two Seven Only

Rupees llil AND Paise Three fhrce Only

HISCOPINE PAEDIATRICSAME AS IN ITEM

50mlBottle

W

1041

1050

Page 9 of 50

Employes' Sbte fnsurance Corporation

Rate Schedule of Running Rate Contract No. U-25/12l142C-l46Cl2OL9-Med V FOR RC 143C

Valid from Thursday, October 14d' 2021 to Tuesday, October 31't 2023


Firm Rate/unit

FirmPacking

Preference Dexription of stores ac@pted

1055 Bisoprolol Tab/Cap-

Each Tab/Cap to contain: Bisoprolol Fumerate 5 mg

1 Tab/Cap

IntasPharmaceuticalsLtd

1.67 Perl Tab/Cap

10 Tabs FIRST

Rapes One AND Pai* Six Seven Only

Trimetazidine Tab/Cap-

Each Tab/Cap to contain: Trimetazidine Hcl 20 mq

l Tab/Cap



0.52 Perl Tab/Cap

10 Tabs FIRST THEMIDONSAME AS IN ITEM

6.43 Per lOTabs SECOND FTAVEDON 20l Tab/Cap SAMEAS IN ITEM

1074 Isoxsuprine Tab/Cap-Each Tab/Cap to contain: Isoxsuprine Hcl 10 mg

l Tab/Cap

OverseasHealthcarc Art Ltd


71.15 Perlm! ViaUAmp

PREGNIN

SAME AS IN ITEM

BOTROPASE INJECTIONSAME AS IN ITEM

1ml ViaUAmp

FIRST

Rupees *venty One AND Paise One Fiye Only

1078 Haemo-Coagulant Inj-Each ml to contain : Aqueous Solution OfHaemocoagulase (One I U/CU/NIH Unit) IsolatedFrom Venom Of Bothrops, Jararaca Or BothropsAtrox Containing Sodium Chloride 0.9olo

1ml Vial/ Amp

Page 10 of 50

// frr

Firm Name

BISELECT-5

SAME AS IN TTEM

1063

Rupees Nil AND Paise Five tuw Only

Rupees Six AND Paise Four Thrce Only

0.54 Perl Tab/Cap

10 Tabs FIRST

Rupes llil AND Paise Five Four Only


Rate Schedule of Running Rate Contract No. U-25/12l142C-l46Cl2OLg-Med V FOR RC 143C

Valid from Thursday, October 14th 2021 to Tuesday, October 31't 2023

fEm No Drug Desciption Packing

Firm Rate/unit Packing

Preference Dexiption of stores acepfud

tt24

1131 Sodium Valproate Tab/Cap -

Each Tab/Cap to contain: Sodium Valproate 200m9.

I Tab/Cap

USV Private Limited 3.25 Perl Tab/Cap

10 Tabs FIRST

10 Tabs FIRSTHabPharmaceutacals &Research Ltd

Psychotropics IndiaLimited

Sanofi - Synthelabo(India) PravateLimited

0.80 Perl Tab/Cap

0.86 Per 10 Tabs SECOND TAB VALATE 2OO

l Tab/Cap (ENTERIC COATED GASTRO

RESISTANT TABLET)

SAME AS IN TTEM

Rupees Nil AND Paise Eight Six Only

2.47 Pq 10 Tabs THIRD VALPARIN ALKALTES 2OO

l Tab/Cap (EACH ENTERIC COATED

GASTRO RESISTANT TABLFT)

SAME AS IN ITEM

Ru@es Two AND Paise Four *ven Only

Page 11 of 50

Firm Name

Nimodipine Tab/Cap-

Each Tab/Cap to contain: Nimodipine 30 mg

l Tab/Cap

NIMODIPSAME AS IN ITEM

EPIVALPRATE-2OO(ENTERIC COATED TABLET)

SAME AS IN ITEM

Rupees Thrce AND Paise Two Five Only

Rupees Nil AND Paise Eight Zero Only

Employees' State Insura nce Corryration

Rate Schedule of Running Rate Contract No. U-25/12l142C-L46C|2OL9-Med V FOR RC 143C

Valid from Thursday, October t4th 2O2l to Tuesday, October 31't 2023



Prefercnce Description of stores accepted

1t32 Levodopa & Carbidopa Tab/Cap-

Each Tab/Cap to contain: Levodopa 250 mg,

Carbidopa 25 mg

1 Tab/Cap

Rupees Two AND Paise Eight Ze,o Only

1348 Valsartan Tab/Cap-

Each Tab/Cap to contain: Valsartan B0mg

1 Tab/Cap

Sun PharmaLaboratoriesLimited

2,80 Per

I Tab/Cap

6.30 Perl Tab/Cap

10 Tabs FIRST VALSALAR-80SAME AS IN TTEM

10 Tabs FIRST ZYTAND( 5SAME AS IN TTEM

Rupes One AND Paise Nine Eight Only

t349 Ivletolazone Tab/Cap-

Each Tab/Cap to contain Metolazone 5mg

l Tab/Cap

8.11 Per 10 Tabs SECOND METOZ 5 MGl Tab/Cap SAME AS IN ITEM

Rupees Eight AND Paise One One Only

Page 12 of 50

ftem No

Lark Laboratories(India) Ltd.

1.98 Perl Tab/Cap


Zydus HealthcareLtd

CentaurPharmaceuticalsPrrt. Ltd.

Rupees Six AND Paire Thrce Zerc Only

/"'Y

Employees' State fnsu ra nce Corporation

Rate Schedule of Running Rate Contract No, U-25/12l142C-L46C|zOLg-Med V FOR RC 143C

Valid from Thursday, October 14rh 2O2L to Tuesday, October 31st 2023

Packingfbm No Drug Description


Prefetence Description of storcs ac@phd

t370 Torsemide Tab/Cap-

Each Tab/Cap to contain: Torsemide 10mg

l Tab/Cap

Cipla Limited


CentaurPharmaceuticalsPt t. Ltd.




7.7O Perl Tab/Cap

10 Tabs FIRST

10 Tabs FIRST

COVERSYT PLUS

SAME AS IN ITEM

CYCKLATRAN-MSAME AS IN ITEM

0.57 Per 15 Tabs FIRST DYTOR 10l Tab/Cap SAME AS IN rTEM

Rupees Nil AND Paise Five Seven Only

1.65 Per 15 Tabs SECOND TOR-10l Tab/Cap SAME AS IN ITEM

Rupees One AND Pai* Six Six Only

1,89 Per loTabs THIRD MELTOR 1OMG

l Tab/Cap SAME AS IN rTEM

Rupees One AND Paise Eight Nine Only

1372 Perindopril + Indapamide Tab/Cap-


Perindopril Erbumine 4mg, Indapamide 1.25m9

l TabiCap

Rupees Seven AND Paise Seven Zerc Only

1393 l'lefenamic + Tranexamic Acid Tab/Cap-

Each Tab/Cap to contain: Mefenamic Acid 250m9,

Tranexamic Acid 500m9

l Tab/Cap

Rupees Four AND Paise Nine Zero Only

7.L7Per 6Tabs SECOND TRENAXAMFI Tab/Cap SAME AS IN ITEM

Rupees Seven AND Paise One Seven Only

Page 13 of 50

4.90 Perl Tab/Cap

/^y

Employees' Sbte fnsurance Corporation

Rate Schedule of Running Rate Contract No. U-25/12l142C-146C12019-Med V FOR RC 143C




Preference De*rtption of storcs ac@phd

1420 Telmisartan Tab/Cap-

Each Tab/Cap to contain: Telmisartan 40mg

1 Tab/Cap

0.57 Perl Tab/Cap

15 Tabs FIRST TELDIL 40SAME AS IN ITEM

Rupees Nil AND Pai* Six Nine Only

0.95 Per 10 Tabs THIRD TELMIKAA 40l Tab/Cap SAI.{E AS IN ITEM

Rupees Nil AND Paise Nine Five Only

t42r Perindopril + Amlodipine Tab/Cap-Each Tab/Cap to contain: Perindropil 4mg,Amlodipine 5mg

l Tab/Cap

TroikaaPharmaceuticalsLimited



6.45 Perl Tab/Cap

0.79 Perl Tab/Cap

lOTabs FIRST

10 Tabs FIRST

covERsYL - AM 415SAME AS IN ITEM

HYDIL 25SAME AS IN ITEM

Rupees Six AND Pai* Four Five Only

1 Tab/Cap

Rupees Nil AND Paise Seven Nine Only

Page 14 of 50

ftem No

Rupees Nil AND Paise Five Seven Only

Psychotropics India 0.69 Per 10 Tabs SECOND TELPIT 40Limited l Tab/Cap SAME AS IN ITEM

PulsePharmaceutical Pt tLtd

1461 Hydroxyzine Hydrochloride Tab/Cap-

Each Tab/Cap to contain:Hydroxyzine Hydrochloride 25mg

{*

Em ployees' State fnsu ra nce Corporation

Rate Schedule of Running Rate Contract No.U-25lL2lL42C-l46Clz0l9-Med V FOR RC 143C

Valid from Thursday, October 14th 2021 to Tuesday, October 31st 2023



FirmPacking

t522 Inhaler -


Ipratropium 20mca,

Levosalbutamol 50mcg

Cipla Limited

0.45 Perdose

5.88 Per2ml Amp

SALIPRAIR L 20 HFA

INHALATIONSAME AS IN ITEM

Rupees Nil AND Paise Four Five Only

Ruryes Nil AND Paise Four Five Only

L524 Budesonide Respule-

Each 2ml to contain :

Budesonide 1mg Steriod Nebulizing Fluid

2ml Amp

Cipla Limited FIRST BUDECORT lMGSAME AS IN ITEM

Rupees Five AND Paise Eight Eight Only4

Page 15 of 50

Prefercnce De*ription of stores accepfud

Equal to or more than 120 N4DI

Midas CarePharmaceuticalsArt. Ltd.

0.45 Per 200 MDI FIRST DUOLIN CFC FREE INHdose (WITH DOSE COUNTER)

SAME AS IN ITEM

24O MDI FIRST

2mlRespule

l"Y



Preference Description of stores acepted

Tlotropium Bromide Rotacap-

Each Rotacap to contain : llotropium Bromide IP/BP

Eqv. to Tiotropium Bromide Monohydrate 18mcg.

l Rotacap

Cipla Limited 30 CapsBottle

Rupees One AND Pai* Two Nine Only

1.29 Per1 Rotacap

4.03 Perl Tab/Cap

FIRST TIOVA ROTACAPS

SAME AS IN ITEM

IVAMAC 5SAME AS IN ITEM

10 Tabs FIRST

Zydus HealthcareLtd



1.39 Per 15 Caps SECOND TIOMIST RESPICAPS1 Rotacap Bottle SAME AS IN ITEM

2,27 Per 15 Caps THIRD AEROTROP1 Rotacap Bottle (HARD GELAIN CAPSULE)

SAME AS IN ITEM

Rupees Two AND Paise Two Seven Only

1530 l Tab/Cap

Rupees Four AND Paise Zero Thrce Only

Page 16 of 50

Employees' State Insura nce Corporation

Rate Schedule of Running Rate Contract No. U-25/121142C-L46C|2OL9-Med V FOR RC 143C

Valid from Thursday, october 14th 2021 to Tuesday, October 31't 2023

Firm Name

1525


Rupees One AND Paise fhrce Nine Only

Ivabradine Tab/Cap-Each Tab/Cap to contain: Ivabradine 5mg

15.00 Per 14 tabs SECOND CORAI-AN sMGl Tab/Cap Manufactured by:-

Les Laboratoires ServierIndustrie, FranceSAME AS tN ITEM

Ru@es Fifteen Only

t:


Rate Schedule of Running Rate Contract No. U-251121142C-L46C|zOL9-Med V FOR RC 143C

Valid from Thursday, October L4rb 2O2l to Tuesday, October 31i 2023



Prefercnce

1668 Olmesartan Tab/Cap-

Each Tab/Cap to contain : Olmesartan 20mg

Sml InJ. FIRST

Zydus HealthcareLtd

13125.00 Per5ml

1.33 Per 10 Tabs SECOND OIMY 20l Tab/Cap SAMEAS IN ITEM

Rupees One AND Pai* Thrce Three Only

3.00 Per 15 Tabs THIRD OTMESAR 20I Tab/Cap SAME AS IN ITEM

OLIPIL 20SAME AS IN ITEM

FLOSEAT sMLManufactured By:-Baxter HealthcareCorporation, 21026Alexander court HaywardCalifornia US 94545SAME AS IN ITEM

Rupees Thte Only

t670 Haemostatic-

Each 5ml to contain:Haemostatic Matrix With Prefilled Gelatin Granules

In Syringes

5ml

PaBe 17 of 50

De*ription of stores ac@pted

1 Tab/Cap

Psychotropics India 0.82 PerLimited l Tab/Cap


Baxter (India) PvtLtd

10 Tabs FIRST

Rupees l{il AND Paise Eight Two Only

Ruwes Thifteen Thoumnd One Hundrcd Twenty Five OnlP

7^*t:

Employees' Sbte Insuran@ Corporation

Rate Schedule of Running Rate Contract No, U-25/12l142C-1,46C12OL9-Med V FOR RC 143C

Valid from Thursday, October L4th 2021. to Tuesday, October 31st 2023



t674 Sumatriptan Tab/Cap-

Each Tab/Cap to contain: Sumatriptan 50mg

1 Tab/Cap


Rupees Thirty Three Only

1681 Citicoline Tab/Cap-

Each Tab/Cap to contain: Citicoline 500 mg

1 Tab/Cap

PulsePharmaceutical hrtttd

Bajaj HealthcareLimited

33.00 PerI Tab/Cap

9.12 Perl Tab/Cap

10 Tabs FIRST COLIBRA

SAME AS IN ITEM

Rupees Nine AND Paise One Two Only

LO,77 Per 10 Tabs SECOND SAME AS IN ITEMl Tab/Cap

Rupees Ten AND Paise Seven Seven Only

USV Private Limited 2O.O0 Per 10 Tabs THIRD CITINERVEl Tab/Cap SAME AS IN ITEM

Rupees Twenty OrtfA

Page 18 of 50

Firm NameI Ptefetence

I

Oexriefion of sbrcs acepEd


4r-^-,r-,r r'-/.

Employes' StaE Insurance Corporation

Rate Schedule of Running Rate Contract No.U-25lLzlL42C-l46Clz0lg-Med v FOR RC 143C

Valid from Thursday, October L4rh aOZL to Tuesday, October 3L* 2023


FirmPacking

Preference Description of sfurcs acepted

1682 Divalproex Sod. Tab/Cap-

Each SR/ER/CR Tab/Cap to contain:

Divalproex Sod. 250m9

PulsePharmaceutical PvtLtd

l0 Tabs FIRST DIOVAT XR 250SAME AS IN ITEM

10 Tabs FIRST DIOVATXR 5OO

SAME AS IN ITEM

Rupees Six AND Paise Nine Zero Only


PulsePharmaceutical hrtLtd

2.53 Perl Tab/Cap

Rupees One A^lD Pai* Eight Zero Only

4.48 Per lOTabs THIRD DIVAA-OD 250l Tab/Cap SAME AS IN ITEM

Rupees Four AND Paise Four Eight Only

1683 Divalproex Sod. Tab/Cap-

Each SR/ER/CR Tab/Cap to contain:

Divalproex Sod. 500m9

1 Tab/Cap

IntasPharmaceuticalsttd

/-^:

Page 19 of 50

ftem No


1 Tab/Cap

1,71 Per1 Tab/Cap

Zydus HealthcareLtd

Rupees One AND Pai* Seven One Only

1.80 Per 10 Tabs SECOND DMTPRO XR 250l Tab/Cap SAME AS IN ITEM

Rupees Two AND Paise Five Thre Only

6.90 Per 10 Tabs SECOND DMA-OD 5OO

I Tab/Cap SAME AS It{ ITEM

Employees' State fnsura nce Corporation

Rate Schedule of Running Rate Contract No. U-25/12l142C'L46C|2OLg-Med V FOR RC l43C

Valid from Thursday, October L4th 2O2l to Tuesday, October 31st 2023

Packingftem No Drug Description


Preference

t749 Equal to or more than 120 MDI

Rupees Nil AND Paise Two Seven Only

Cipla Limited 2OO MDI SECOND LEVOTIN CFC FREE INH(Wml DosE couNTER)

SAME AS IN ITEM

Rupees Nil AND Paise Three Thrce Only

Nebivolol Tab/Cap-

Each Tab/Cap to contain: Nebivolol Smg

1 Tab/Cap

10 Tabs FIRSTMacleodsPharmaceuticalsLimited

GennovaBiopharmaceuticalsLtd.

1,80 Perl Tab/Cap

22990.00 Per l Viall Vial

240 MDI FIRST

FIRST ELAXIM /+O

SAME AS IN ITEM

Pe0.33dose

r

t752 1 Vial

Page 20 of 50

Firm Ndme De*ription of storcs acephd

Inhaler-


Levosalbutamol Tartrate 50mcg

175t


O.27 Perdose

BONAIR L HFA INHALATIONSAME AS IN ITEM

NEBIMAC 5 MG

SAME AS IN ITEM

Rupees One AND Paise Eight Ze,o Only

Tenecteplase 40mg Inj-Each Vial to contain: Tenecteplase 40mg

Rupees TwentyTwo Thouand Nine Hundrcd Ninev Only

4"-,r*/_

Employes' Sbte fnsuran@ Corporation

Rate Schedule of Running Rate Contract No. U-25/12l142C-L46Cl2Ol9-Med v FOR RC 143C

Valid from Thursday, October L4th 2O2L to Tuesday, October 31"t 2023



Preference Description of stores accepted

1754 Indapamide SR + Amlodipine Tab/Cap-


Tab/Cap Indapamide SR 1.5 mg,

Amlodipine Besylate Equivalent To Amlodipine 5 mg

1 Tab/Cap



Cipla Limited

Cipla Limited

10 Tabs FIRST NATRILAM 5SAME AS IN ITEM

Rupees Seven AND Paise Seven Nine Only

0.53 Per 240 MDI FIRST FLUSAL 250 HFA INHALATION

dose SAME AS IN ITEM

Rupees Nil AND Paise Six Three Only

0.86 Perdose

3.25 Perdose

120 MDI SECOND SEROFTO 250 CFC FREE INHSAME AS TN ITEM

2OO MDI FIRST SEROFTO 250 AUTOHALER

SAME AS IN ITEM

Rupees Three AND Paise Two Fi Onlyve

1840 Inhaler-

Each Delivered Dose to contain:

Salmetrol Xinafoate IP Equivalent to Salmetrol IP25 pg, Fluticasone Propionate IP 250p9, Excipients

& Propellant 1, 1,1,2 Tetrafluoro Ethane HFA 134a


with/ without spacer

1843 Autohaler-Each Delivered Dose Of Autohaler to contain:

Salmeterol (As Salmeterol Xinafoate) IP 25 mcg,

Fluticasone Propionate IP 250mcg Suspended In

Propellant 134a Q.S. (Contalns Absolute Alcohol Ip

5o/o v lv)


Page 21 of 50

ftem No

7.79 Perl Tab/Cap

Rupees Nil AND Paise Eight Six Only

l'^:


Rate Schedule of Running Rate Contract No. U-251121142C-L46C|2OL9-Med V FOR RC 143C




Preference Description of stores accepfud

1845 Metoprolol Succinate SR Tab/Cap-

Each SR Tab/Cap to contain:

I4etoprolol Succinate 23.75m9 Equivalent To

It4etoprolol Tartrate 25mg

1 Tab/Cap

PulsePharmaceutical hrtLtd

Cipla Limited

MacteodsPharmaceutacalsLimited


O.47 Perl Tab/Cap

0,52 Perl Tab/Cap

15 Caps

.10rabs FIRsr l_"tl9gE!-2!_: . ^_-(uNCoATED PROLONGED

RELEASE TABLEI)

SAME AS IN TTEM

Rupees Nil AND Paise Four Seven Only

Rupees Nil AND Paise Five Two2.7O Per 10 Tabs THIRDl Tab/Cap

METOLAR XR 25 CAP(HARD GELANN EXTENDED-

RELEASE CAPSULE)

SAME AS IN ITEM

OnlyMETOMAC 25(EffENDED -RELEASE TABLEI)SAME AS IN ITEM

E50MGSAME AS IN ITEM

Rupees Two AND Paise Seven Zero Only

1.59 Per 10 Tabs FIl Tab/Cap

Rupees One AND Paise Six Nine Only-r-

1 Tab/Cap1869 Amisulpride Tab/Cap-

Each Tab/Cap to contain: Amisulpride 50mg

Page 22 of 504,-/"'1il-t-

Employees' State Insu ra nce Corporation

Rate Schedule of Running Rate Contract No. U-25l12l142C-L46C|2OL9-Med V FOR RC 143C




Preference Description of stores accepfud

1870 Quetiapine Tab/Cap-

Each Tab/Cap to contain: Quetiapine 25 mg

l Tab/Cap



0.94 Perl Tab/Cap

1.51 Perl Tab/Cap

12.91 Perl Tab/Cap

10 Tabs FIRST

10 Tabs FIRST

QUSER 25SAME AS IN ITEM

QUSER 100SAME AS IN ITEM

PEXEP-CR-25

SAME AS IN ITEM

Rupees Nil AND Paise lline Four Only

1.99 Per 10 Tabs SECOND QUTAN-2Sl Tab/cap SAME As IN ITEM

Rupes One AND Pai* Nine Nine Only

1 Tab/Cap

Rupees mre AllD Paise Nine Four Only

l Tab/Cap

Rupees Twelve AND Paise Nine One Onlyo

Page 23 of 50




loTabs FIRST

L87t Quetiapine Tab/Cap-

Each Tab/Cap to contain: Quetiapine 100 mg

Rupees One AND Paise Five One Only

3.94 Per 10 Tabs SECOND QUTAN-100l Tab/Cap SAME AS IN ITEM

1873 Paroxetine CR Tab/Cap-

Each CR Tab/Cap to contain: Paroxetine 25mg

/**:


Rate Schedule of Running Rate Contract No, U-25/12l142C-L46C|zOLg-Med V FOR RC 143C

Valid from Thursday, October L4rh 2O2! to Tuesday, October 31't 2023

frcm No Drug Description Packing

Firm Name FirmPacking

Prefetence De$ription of stores acepted

Levetiracetam Tab/Cap-

Each Tab/Cap to contain: Levetiracetam 500m9

1 Tab/Cap


2.42Perl Tab/Cap


Cipla Limited

Ruwes TWo AND Paise Four Two Only

2.90 Per 10 Tabs SECOND SAME AS IN ITEMl Tab/Cap

Rupees Two AND Paise Nine Zeru Only

2,92Per 15 Tabs THIRD LEVEPSY 5OO SAME AS INl Tab/Cap ITEM

Rupes TWo AND Paise Nine TWo Only

1880 Levetiracetam Tab/Cap-

Each Tab/Cap to contain: Levetiracetam 250mq

l Tab/Cap

Zydus Healthcarettd

1,49 Per

l Tab/Cap10 Tabs FIRST Epinext 250

SAME AS IN ITEM

Rupees One AND Pai* Four Nine Only

1.54 Per 15 Tabs SECOND LEVEPSY 250l Tab/Cap SAME AS IN ITEM

Rupees One AND Pai* Five Four Only

1.80 Per 60 Tabs THIRD LEVEI 500 MGl Tab/Cap SAME AS IN ITEM

Page 24 of 50

Firm Rate/unit

t879

IO Tabs FIRST EPINEXT 5OO

SAME AS IN ITEM

PulsePharmaceutical hrtttd

Cipla Limited

Rupees One AND Paise Eight Zero Only4)

/**

Employees' Sbte f nsu ra nce Corporation

Rate Schedule of Running Rate Contract No. U-25/12l142C-t46ClzOL9-Med V FOR RC 143C




Preference Description of stores ac@pted

1883 Lamotrigine Tab/Cap-

Each Tab/Cap to contain: Lamotrigine 100m9

Rupees Six AND Paise One Eight Only

2014 1 Tab/Cap


Lark Laboratories(India) Ltd.

zydus Healthcar€Ltd

Cipla Limited

Midas CarePharmaceuticalsPl^. Ltd.

6.18 Perl Tab/Cap

1.08 Perl Tab/Cap

0.30 Perdose

0.34 Perdose

10 Tabs FIRST

10 Tabs FIRST MONTETAR-10SAME AS IN ITEM

Rupees One AND Pai* Ze,o Eight Only

1.98 Per lOTabs SECOND ODIMONT lOl Tab/Cap SAME AS IN ITEM

R One AND Paise Nine t

2OO MDI FIRST

24O MDI SECOND BESOT{E 2OO

SAME AS IN ITEM

Rupees Nil AND Paise Thrce Four Only-

2015 Beclomethasone Dipropionate IP 200mcg (HFA

Technology) Inhaler-

Each l\4etered Dose to contain:

Beclomethasone Dipropionate IP 200mcg(HFA Technology)

Page 25 of 50

l Tab/Gp

Montelukast Sodium Tab/Cap-


Montelukast Sodium 10mg

LAMEZ-1OO

SAME AS IN ITEM

BECLATE 2OO CFC FREE INHSAME AS IN TTEM

Rupees Nil AND Paise Three Zem Only


l^a


Rate schedule of Running Rate contract No. u-25/12l142c-t46cl2oL9-Med v FoR Rc 143c

Valid from Thursday, October 1#h 2021 to Tuesday, October 31't 2023



Prefercnce Description of s'tores ac@ptcd

2019 Indapamide (As SR)1.5m9 , Amlodipine Besilate

Equivalent to Amlodipine 2.5m9, Excepients QS Film

Coated Bi-Layered Tab/Cap-Each Film Coated Bi-Layered Tab/Cap Contains:

Indapamide (As SR)1.5m9 ,

Amlodipine Besilate Equvalent To Amlodipine2.5m9, Excepients QS

Rupees Seven AND Paise Four One Only

2022 l Tab/Cap


ZuventusHealthcare Limited

7.41Perl Tab/Cap

10 Tabs FIRST

lOTabs FIRST

NATRILAM 2.5SAME AS IN ITEM

Ruwes One AND Pai* Seven Seven Only

2.4OPer l0Tabs SECOND ARTIFLO2l TAb/Cap SAME AS IN ITEM

Rupees Two AND Paise Fourzeru Only

2060 Ambroxol + Terbutaline Tab/Cap-Each Uncoated Tab/Cap to contain:Hrdrochloride 30 mg, TerbutalineEquivalent to Terbutaline 2.5 mg

Ambroxol

Sulphate

1 Tab/Cap

2.31 Perl Tab/Cap

AMBROLITE ST

SAME AS IN ITEM

Rupees Two AND Paise Thrce One Only

Page 25 of 50

ftem No

1 Tab/Cap

Acenocoumarol / Nicoumalone Tab/Cap-

Each Tab/Cap to contain:Acenocoumarol / Nicoumalone 2mg


L.77 Petl Tab/Cap

ACENOMAC 2SAME AS IN ITEM

Tablets (India)Limited

10 Tabs FIRST

/"-*


Rate Schedule of Running Rate Contract No. U-25 | l2l t420-t46gl 20t9-Med V FOR RC 143C

Valid from Thursday, October l4th 2O2l to Tuesday, October 31st 2023

Item No Drug Description Packing



Ambroxol + Terbutaline Syp-

Each 5 ml to contain: Ambroxol Hrdrochloride IP 30

m9, Terbutaline Sulphate IP Equivalent toTerbutaline 2.50 mg, Guaiphenesin IP 50 mg,Menthol IP 0.5 mq

100m1 Bottt

Rupees Twenty Nine AND Paise One Two Only

2063 Inhaler-

Each Inhaler to contain:

Fluticasone Propionate 250mca,

Formoterol Fumarate 6mcq




29.12 Per100m1 Bottt

0,73 Perdose

0,89 Perdose

6.80 Perl Tab/Cap

FIRST

240 MDI FIRST

AMBROLITE 25 1OOML

SAME AS IN ITEM

FTUTFOR 250 INHATATIONSAME AS IN ITEM

KIMETXL - 50SAME AS IN ITEM

Rupees Nil AND Paise Seven Thrce Only

120 MDI SECOND MAXIFLO 250 INH(WITH DOSE COUNTER)

SAME AS IN ITEM

Rupees Nil AND Paise Eight Nine Only

Rupees Six AND Paise Eight Zerc Only

SC)Metoprolol Tab/Cap-

Each Prolonged Release Film Coated Tab/Cap tocontain : S(-)Metoprolol Succinate 47.50 mg Eqv. toSC) Metoprolol Tartrate 50 mg

1 Tab/Cap

Page 27 ol 5O

L/

Firm Name

2061

Tablets (tndia)Limited

Cipla Limited

100m1

Boftle

10Tabs FIRST

2067

*T

Employees' State Insurance Corporation

Rate Schedule of Running Rate Contract No. U-25lL2l L42C-t46ClzOLg-Med V FOR RC 143C

Valid from Thursday, October L4th 2O2L to Tuesday, October 31't 2023


FirmPacking

Prefercnce Dexription of stores accepfud

S(-)Metoprolol Tab/Cap-

Each CVPR/DR/SR/MR Tab/Cap to contain :

S(-)Metoprolol Succinate 23.75 mg Eqv. to S(-)Metoprolol Tartrate 25 mg


5.80 Perl Tab/Cap

10 Tabs FIRST KIMET XL - 25SAME AS IN ITEM


2069 licagrelor Tab/Cap-

Each Tab/Cap to contain:Tlcagrelor 90mg1 Tab/Cap

Ruryes Thirteen AND Paise Seven Seven Only

2070 Ivabradine Tab/Cap-

Each Film Coated Tab/Cap to contain: Ivabradine Hcl Equivalent To IvabradineT,5mg

1 Tab/Cap

Bajaj HealthcareLimited



L3.77 Perl Tab/Cap

17.86 Perl Tab/Cap

6.71 Perl Tab/Cap

Rupees Seventeen AND Paise Eight Six Only

Indapamide + Amlodipine Tab/Cap-

Each Film Coated Bilayered Tab/Cap to contain

Indapamide (As Sustained Release) 1.5m9 and

Amlodipine Besilate Equivalent to Amlodipine 10mg

l Tab/Cap

10 Tabs FIRST

Rupees Six AllD Paise Seven One Only

Page 28 of 50

a


2068 1 Tab/Cap

14Tabs FIRST

Rupees Five AND Paise Eight Zero Only

CORALAN 7.sMGManufactured byi-Les Laboratoires SeruierIndustrie, FranceSAME AS IN ITEM

NATRILAM 10SAME AS IN ITEM

2074

f^^r

Employees' Sbte fnsurance Corporauon

Rate Schedule of Running Rate Contract No. U-25/12l142C-l46Cl2OL9-Med V FOR RC 143C

Valid from Thursdan October 14th 2021 to Tuesday, October 31* 2023

ftem No Drug Desciption Packing



2076 f4icronised - Purified Flavonoid Tab/Cap-

Each Film Coated Tab/Cap to contain: Micronised -

Purified Flavonoid Fraction 1000m9-Composed OfDiosmin 900m9 (90olo) And Flavonoids Expressed As

Hesperidin 100mc ( 100/o)

1 Tab/Cap

Baxter (India) ArtLtd

14.29 PerI Tab/Cap

23094.00 Per1 PFS


10 Tabs

Rupees Fourteen AND Paise TWo Nine Only

10ml PFS FIRST FLOSEAL 1OML

Manufactured Byr-Baxter HealthcareCorporation, 21026Alexander court HaywardCalifornia US 94545SAME AS IN ITEM

Rupees Twenty Three Thousand Ninety Four Only

2078 Apixaban Tab/Cap-

Each Film Coated Tab/Cap to contain:Apixaban 2.5m9

1 Tab/Cap

FIRST DAFLON 1OOOMG

SAME AS IN ITEM

50.54 Perl Tab/Cap

10 Tabs FIRST ELTQUTS 2.sMGManufactured By:-M/s. Pfizer ManufacturingDeutschland GmbH,Betriebsstatte FreiburgMooswaldallee 1 NA Freiburg(Germany) -79090SAME AS IN ITEM

Rupees Fifty AND Paise Five Four Onlya

Hemostat-

Each PFS to contain:Hemostatic Matrix With

Syringe 10ml

Thrombin In Prifilled

1 PFS

Page 29 of 50

Pfizer Limited

2077

Employees' SEte fnsurance Corporation

Rate Schedule of Running Rate Contract No. U-25l12l142C-t46Clz0tg-Med V FOR RC 143C

Valid from Thursday, October l4th 2O2L to Tuesday, October 31st 2023

ftem No Drug Desciption Packing


FirmPacking

Preference Dexription of storcs acepted

Apixaban Tab/Cap-

Each Film Coated Tab/Cap to contain:

Apixaban 5mg

Rupees Fifry TWo AND Paise Nine Five Only

2080 Dabigatran Tab/Cap-


Dabigatran Etexilate 110 mg

l Tab/Cap

BoehringerIngelheim IndiaPrivate Ltd

10.50 Perl Tab/Cap

50.00 Perl Tab/Cap

10 Tabs FIRST

Rupees Fifty Only

10 Caps FIRST SAME AS IN ITEM

Rupees Ten AM Paise Five Zero Only

10 Caps SECOND

ErrQUrs 5MGManufactured By:-M/s. Pfizer ManufacturingDeutschland GmbH,Betriebsstatte FreiburgMooswaldallee 1 NA Freiburg(Germany) -79090SAME AS rN rrEM,.

PRADAXA 150 MG

Manufactured by:-Boehringer IngelheimPharma GmbH & Co. KG,

Binger Str.173,55216,Ingelheim am Rhein,GermanySAME AS rN rTEU

Page 30 of 50

2079 l Tab/Cap

Pfizer Limited

PreciseChemipharma ArtLtd

52.95 Per

l Tab/Cap

{^^:

Employees' State fnsuran@ Corpration

Rate schedule of Running Rate contract No. u-2slL2lL42c-t46clzot9-Med v FoR Rc 143c

Valid from Thursdan October 14b 2O2l to Tuesday, October 31't 2023

Description ll4ckin9


Prefercnce De%ription of stores acepted

2081 4ml

WallacePharmaceuticalsPvt. Ltd.

13545.0O Per 4ml Kit4ml

TI$SEL LYOFibrjn Sealant VH ID powder and solventcontains

Component -1 contain sealer protein solutjon

a. 1 vial of human fibrinogen

b. 1 vial of synthetic aprotinin solutionC.omponent -2 hrombin solution containa. 1 vlal thrombin 500 IU (Lyophilized)

b. 1 vial of calcium chloride

Manufactured By:-Baxter AG, A-L22\ Vienna,Industriestrasse 67 Vienna -1221 Vienna (Austria)SAME AS IN ITEM

Rupees Thirteen Tltousand Five Hundrd Forty Fiye Only,

20.60 Per100 ml Bott

100m1Bottle

FIRST

Rupees Twenty AND Paise Six Zeru Only

2703 Terbutaline + Guiaphenesin + Ambroxol Syp-

Each 5 ml to contain:

Terbutaline I.P 1.25m9 + Guiaphenesin I.P 50mg +Ambroxol I.P 15mg Syrup Base QS

100 ml Bottle

Page 31 of 50

ftum No

Anticoagulants-

Each Kit to contain:Two Componant Fibrin Sealant With SyntheticAprotinin (4ml)

Baxter (India) PvtLtd

WALTUZ-BRSAME AS IN ITEM

FIRST

Employees' State Insura nce Corporation

Rate Schedule of Running Rate Contract No. U-25l12l142C-L46C|2OLg-Med V FOR RC 143C




Preference De*ription of storcs ac@pted

Dextromethorphan + CPM Syp-

Each 5 ml to contain: Dextromethorphan I.P 10mg

+ Chlorpheniramine lulaleate I.P 2mg Syrup Base QS

100m1 Bottle

Zenith Drugs hrt,Ltd.

WallacePharmaceuticalsPvt. Ltd.

Gopaldas VisramAnd CompanyLimited

18.43 Per

100m1 Bott

948.00 Per10ml

lOOmlBottle

10ml Vial FIRST

200MeteredDose

FIRST

FTBRICOR

SAME AS IN ITEM

GTN SPRAY

SAME AS IN ITEM

FIRST SAME AS IN ITEM

Rupees Eighteen AND Paise Four Three Only

19.70 Per 100m1 SECOND WALTUZ-DX100m1 Bott Bottle SAME AS IN ITEM

Rupees Nineteen AND Paise Seven ze,o Only

42.50 Per IOOmI THIRD SAME AS IN ITEM100m1 Bott Bottle

Rupees Forly Two AND Paise Five Zero Only

Ibutilide-Each ml to contain:

Ibutilide Fumarate 0.1m9 ( Equivalent To IbutilideFreebase 0.087mg), Water For Injection

10ml

2207 Glyceryl Trinitrate Spray-


Glyceryl Trinitrate Spray -0.4 Mg

2OO MD

MedleyPharmaceuticalsLtd

Rupees Two Hundrcd Thirty Only

Page 32 of 50

2204


Rupees Nine Hundrcd FoW Eight Only

230.00 Per2OO MD

2205

f<


Rate Schedule of Running Rate Contract No. U-25l12l142C-L46C|zOL9-Med V FOR RC 143C


ftem No Drug Description Packinq


Preference De*ription of stotes accepEd

Human Albumin-

Each Bott to contain- Human Albumin 25olo 100 ml

In Flexible, Self Collapsible- Closed System Bags

Baxalta BioscienceIndia PrivateLimited

Roche Products(India) Pvt Ltd

4233.00 Per

100m1 Bott

81437.00 Per l Vial1 Vial

FLEXBUMIN

Manufactured by:-Baxalta US INC. USA

SAME AS IN ITEM

HEMLIBRA 30 MG

Manufactured by:-M/s. F. Hoffmann-La RocheLtd, Wurmisareg,CH- 4303/ Kaiseraugst,SwitzerlandSAME AS Iil ITEM

100m1

Bag

FIRST

Rupees Four Thousand Two Hundred Thifi Thrce Only.

40754,00 Per l Vial1 Vial

FIRST

Rupees Forty Thousand Seven Hundrcd Fifry Four Only

22t0 Emicizumab Inj-Each Vial Contains :

Emicizumab 60mg For Sub Cut Injection (R-DNA

Oriqin)

1 Vial

FIRST

2209 Emicizumab Inj-Each Vial Contains :

Emicizumab 30mg For Sub Cut Injection (R-DNA

Oricin)

1 Vial

Firm Name

2208 100m1 Bottle

HEMUBRA 60 MG

Manufactured by:-M/s. F. Hoffmann-La RocheLtd, Wurmisweg,CH- 4303, Kaiseraugst,SwitzerlandSAME AS IN TTEM

Roche Products(India) Pr^ Ltd

Rupees Eighty One Thousnd Four Hundrcd Thirty Seven Onllo

Page 33 of 50

Employees' Sbte fnsu ra nce Corporation

Rate Schedule of Running Rate Contract No. U-25lL2lL42C-l46Cl20!g-Med V FOR RC 143C

Valid from Thursday, October 14th 2O2L to Tuesday, October 31st 2023


Firm Rate/unit Packinc

Prefercnce

22t1 Micronized - Purified Flavonoid Tab/Cap-

Each Film Coated Tab/Cap to contain :

Micronized - Purified Flavonoid Fraction 500m9

Composed Of Diosmin 450m9 (90o/o) And

Flavonoids Expressed As Hesperidine 50mq (10olo)

1 Tab/Cap

10 Tabs FIRST DAFLON SOOMG

SAME AS IN ITEM

Rupees Eight AND Paise Eight Eight Only

2299 Telmisaftan Tab/Cap:

Each Tab/Cap to contain: Telmisartan 20mg

1 Tab/Cap

SerdiaPharmaceutacals(tndia) PrivateLimited

PreciseChemipharma hrtLtd

8.88 Perl Tab/Cap

50.00 Perl Tab/Cap

USV Private Limited 0.73 Perl Tab/Cap

10 Tabs FIRST TAZLOC 2OMG

SAME AS IN ITEM

Rupees Nil AND Paise Seven Thrce Only

1.14 Per 10 Tabs SECOND MACSART 20l Tab/Cap SAME AS IN ITEM

One AND Paise One Four

12.50 Perl Tab/Cap


Rupees Tfuelve AND Paise Five Zem Only

10 Caps SECOND

Ruryes Fifty Only

PRADAXA 110 MG

Manufactured by:-Boehringer IngelheimPharma GmbH & Co. KG,

Binger Str.173,552L6,Ingelheim am Rhein,GermanySAME AS IN ITEM

?

Dabigatran Etexilate Tab/Cap-


Dabigatran Etexilate 150m9

1 Tablcap

Page 34 of 50

4

Firm Name De ription of stotes accepfud

BoehringerIngelheim IndiaPrivate Ltd


2302

f'y


Firm Name Fim Rate/unit

FirmPacking

Description of stores ac@phd

Acetyl Salicylic Acid + Atorvastatin Tab/Cap-

Each Tab/Cap to contain:Acetyl Salicylic Acid 75m9, Atorvastatin 20mg

1 Tab/Cap

10 Caps FIRST

Rupees One AND Paise gix Nine Only

2306 Diltiazem CR/ SR/ DR/ MR Tab/Cap-

Each CR/ SR/ DR/ MR Tab/Cap to contain:

Diltiazem 90mg

1 Tab/Cap

Modi MundipharmaPrivate Limited

10 Tabs FIRST

100m1Bottle

FIRST

DILCONTIN XL 90SAME AS IN ITEM

WIROF SYRUP

SAME AS IN ITEM

Rupees One AND Pai*5even One Only

28.30 Per100m1 Bott

Rupees Twenty Eight AND Paise Th,ee Ze,o Only

29.60 Per 100ml THIRD CODICON COUGH SYP

100m1 Bott Bottle SAME AS IN ITEM

2309 Codein Lint, Syp/Susp-

Each 5ml to contain:

Chlorpheniramine Maleate 4mg,

Codeine Phosphate 10mq

100m1 Bottle

Page 35 of 50

Employees' Sbte fnsura nce Corporation

Rate Schedule of Running Rate Contract No. U-25l12l142C-t46Cl2OL9-Med V FOR RC 143C

Valid from ThuEday, October L4rh 2O2L to Tuesday, October 31st 2023

Prefercnce

2303

Cipla Limited ATORLIP ASP 20 CAP(GESTRO - RESISTANT TABLEI)SAME AS IN ITEM

1.69 Per

I Tab/Cap

1.71 Perl Tab/Cap

Windlas BiotechPrivate Limited

ConceptPharmaceuticalsLtd.

Rupees Twenty Nine AND Paise Six Zero OnlYo

fry



Preference


2.7L Perl Tab/Cap

10 Tabs FIRST

BESONE 1OO INHALATIONSAME AS IN ITEM

Rupees Two AND Paise Seven One Only

l Tab/Cap

Cipla Limited 1.19 Perl Tab/Cap

10 Caps FIRST

Rupees One AND Paise One Nine Only


Zim LaboratoriesLimited


Rupees One AND Paise Five Eight Only

1.73 Per 10 Caps THIRD EPINOZ-7sl Tab/Cap SAME AS IN ITEM

Ruryes One AND Paise Seyen Three Only

1040b Beclomethasone Inhaler-Each Metered Dose to contain:

Beclomethasone Dipropionate 100mcg.


O.42 Perdose

240 MDI FIRST

Rupees Nil AND Paise Four Two Only

Page 36 of 50

Employees' State f nsu ra nce Corporation

Rate Schedule of Running Rate Contract No. U-25/12l142C-L46C|zOL9-Med V FOR RC 143C


Description of sfurcs ac@phd

2312 Gabapentin + Nortriptyline Tab/Cap-


Gabapentin 100m9, Notriptyline 10mg

1 TAB/CAP

23t7 Pregabalin Tab/Cap-

Each PLAIN/SR/CR/DR/ER/MR Tab/Cap to contain:Pregabalin 75mg

DOLONEURON NT 1OO

SAME AS IN ITEM

NOVA 75SAME AS IN ITEM

1.58 Per 10 Tabs SECOND GABAWIN 75l Tab/Cap SAME AS IN ITEM

ta


Rate Schedule of Running Rate contract No. U-25l12l142C-!46ClzOLg-Med v FoR Rc 143C

Valid from Thursday, October 14th 2021 to Tuesdan October 31.t 2023

Firm NamePacking

De*ription of s,totes ac@PEd


Ru, Nil AND Paise Four Zerc

0.39 Perl Tab/Cap

MT tOC 50SAME AS IN TTEM

SECOND EMBETA.sOSAME AS IN TTEM

MONICORSAME AS IN ITEM

ASTHALIN ROTACAPS

SAME AS IN ITEM

Rupees Nil AND Paise Three Nine Only

IntasPharmaccuticalsLtd

1.51 Perl Tab/Cap

10 Tabs

10 TAbS FIRST

Rupees One AND Paise Five One OnlY

Paftem No

1043a

Metoprolol Tab/CaP-

Each Tab/CaP to contain :

Metoprolol Tartrate 50 mg

1056a

l Tab/CapIso-sorbide Mononitrate Ta


Iso-sorbide-5-Mononitrate 20 mg

blCap-1060a

Page 37 of 50

/*:

Firm Rate,/unit

Prefercnce

Salbutamol RotacaP-

Each Rotacap to contain : Salbutamol 200mca

1 Cap

Cipla Limited

14Tabs FIRST

0.40 PerI Cap

60 Caps

BottleFIRST

wallacePharmaceuticalsPvt. Ltd.

0.26 Perl Tab/Cap

Rupes Nil AIfiD Pai* ffuo Six OnlYa

,E* =+h rrr*, !c? dS 4F! ,.8 F[

-:: tJi*. g"-dtJc5

Druo

l Tab/Cap

Employees' StaE fnsurance Corporation

Rate Schedule of Running Rate Contract No. U-25l12l142C-t46Cl2OLg-Med V FOR RC 143C





1 Tab/Cap



3.51 Per 14 Tabs FIRST HIPRACINl Tab/Cap Strip SAME AS IN ITEM

Rupees Three AND Pai* Five One Only

5.33 Per 30 Tabs SECOT{D PRAZOPILT XL 2.5l Tab/Cap SAME AS IN ITEM

Rupees Five AND Paise Thrce Thte Only

6.60 Per 30 Tabs THIRD MINIPRESS XL 2.5MGl Tab/Cap Manufactured by:-

M/s, Pfizer Pharmaceuticals[LC,P.O Box No. 628,K 58.2RD 2,Barceloneta P R

00617,USASAME AS IN ITEM

Rupees Six AND Paise Six Zero Only

Prazosin SR Tab/Cap-

Each SR Tab/Cap to contain: Prazosin Hcl 5ms

l Tab/Cap


Pfizer Limited

ftem No

1067b Prazosin SR Tab/Cap-

Each SR Tab/Cap to contain: Prazosin Hcl 2.5 mg


Pfizer Limited

7067c

4.85 Per 14Tabs FIRST HIPRACIN-Sl Tab/Cap SAME AS IN ITEM

Rupees Four AND Palx Eight Five Only

6,17 Per 30 Tabs SECOND PRA:ZOPLL XL 5l Tab/Cap SAME AS IN ITEM

Rupees Six AND Pal* One Seven Only

7.22Per 30 Tabs THIRD MINIPRESS XL sMGl Tab/Cap Manufactured by:-

M/s, Pfizer PharmaceuticalsLLC,P.O Box No. 628,K 58.2RD 2,Barceloneta P R

00617,USASAME AS IN ITEM

RupeesSeven AND Paise Two Two Onty ?

Page 38 of 50 4-.,r'"*

Employ@s' State fnsurance Corporation

Rate Schedule of Running Rate Contract No. U-25/12l142C-l46Cl2Ol9-Med V FOR RC 143C

Valid from Thurcday, October 14lj'2O2L to Tuesday, October 31't 2023

PackingDrug

Firm Name Firm RaE/unit

FirmPacking

Preference Dexription of sbrcs acePhd

1068b Ramipril Tab/ Cap-

Each Tab/ Cap to contain: Ramipril 2.5m9

l Tab/Cap

Cipla Limited

Sanofi IndiaLimited

Cipla Limited


Sanofi IndiaLimited

5.52 Perl Tab/Cap

0.48 Per 10 TAbS FIRST RAMIPRES 2.5

l Tab/Cap SAME AS IN ITEM

Rupees Nil AND Paise Four Eight Only

3.00 Per 1

l Tab/Cap

Rupees

0.1

E 2.5MGIN ITEMn

CARDACE sMG

SAME AS IN ITEM15 tabs

Rupees Five AND Paise Six Two Onll,

/od^-a-.r>-Ati-

Tal

blCiRamipril

Each Ta1068c

Page 39 of 50

ftem lUo

0.50 Perl Tab/Cap

10 TabS FIRST RAMIPRES 5

SAME AS IN ITEM

Rupees Three OnlY

l Tab/Cap

Rupees Nil AND Paise Five Zeto OnlY

10 Tabs SECOND MACPRIL 5SAME AS IN TTEM


Rate Schedule of Running Rate Contract No. U-25l12l142C-l46Cl2OL9-Med V FOR RC 143C





1115b

Rupees Nil AND Paise Four Nine Only

Carbamazepin CR Tab/Cap-

Each CR Tab/Cap to contain: Carbamazepin 200m9

1 Tab/Cap



Cipla Limited

CentaurPharmaceuticalsPrrt. Ltd.


0.49 Perl Tab/Cap

1.11 Perl Tab/Cap

0,55 Perl Tab/Cap

10 Tabs FIRST


15 Tabs FIRST DYTOR 20SAME AS IN ITEM

Rupees One AND Paise One One Only

1370b Torsemide TabiCap-

Each Tab/Cap to contain: Torsemide 20mg

1 Tab/Cap

Rupees Nil AND Paise Six Five Only

2.29Per l0Tabs SECOND MELTOR 20MGl Tab/Cap SAME AS IN TTEM

Rupees Two AND Paise Two Nine Only

3.63 Per 15 Tabs THIRD TOR-2O


Rupees Thrce AND Paise Six Three Only,

PaBe 40 of 50

Firm Name

Phenobarbitone TabiCap-

Each Tab/Cap to contain: Phenobarbitone-30m9

l Tab/Cap

Ll27a

PHENOBARB 30SAME AS IN ITEM

t-


Rate Schedule of Running Rate Contract No. U-25/121142C-t46Cl20t9-Med V FOR RC 143C



Packing

1430b


1.12 Perl Tab/Cap

10 Tabs FIRST

15 Tabs FIRST

CTOBA-s TAB

SAME AS IN ITEM

Rupees One AND Paie One fwo Only

6,67 Per 10 Tabs SECOND SAME AS IN ITEMl Tab/Cap

RuBes Six AND Paise Six Seven Only

324a l Tab/Cap




2.27 Perl Tab/Cap

4,04 Perl Tab/Cap

Rupees TWo AND Paise Two Sevan Only

324b Clobazam Tab/Cap-

Each Tab/Cap to contain: Clobazam I.P.10 mg

1 Tab/Cap

Rupees Four AND Pai*Zerc Four Onllo

Page 41 of 50


Prefercnce Description of storcs ac@pbd

Mirtazapine Tab/Cap-

Each Tab/Cap to contain: Mitazapine 15mg

1 Tab/Cap

MITRAPIT 15SAME AS II{ ITEM

Clobazam Tab/Cap-

Each Tab/Cap to contain: Clobazam 5 mg

15 Tabs FIRST

CTOBA-lo TAB

SAME AS IN ITEMz


Rate Schedule of Running Rate Contract No.U-25lLzll42C-L46Cl2OL9-Med V FOR RC 143C




Prefercnce

Salbutamol Resp. Soln-

Each ml to contain:

Salbutamol Sulphate Eqv. to Salbutamol 5 mg in

Normal Saline Soln.

Cipla Limited

Rupees Eight AND Paise Four Ze,o Only

336b Carvedilol Tab/Cap-

Each Tab/Cap to contain: Carvedilol 6.25m9

l Tab/Cap


Bharat Serums AndVaccines Limited

0.214 Perl Tab/Cap

FIRST

10 Tabs FIRST

1 PFS FIRST

cvl 6.25SAME AS IN ITEM

LONOPIN 2OMG

SAME AS IN ITEM

Rupees Nil AND Paise Four Four Only

366a Enoxaprin Inj-Each PFS to contain:

Enoxaprin Sodium 20 mg / 0.2 ml.

1 PFS

Rupees One Hund,ed Forty Only

280.95 Per 1 PFS SECOND CLEHNE 20MGl PFS Manufactured by:-

M/s. Sanofi WinthropIndustrie, FranceSAME AS IN ITEM

Rupees Two Hundred Eighty AND Paise Nine Five Only

Firm Name Dexription of storcs acephd

32b 15 ml Bottle

8.4O Per15 ml Bott

140,00 Per1 PFS

15mlBottle

ASTHALIN RESPIRATOR SOL.

SAME AS IN ITEM

Sanofi IndiaLimited

{^ryPage 42 of 50


Rate Schedule of Running Rate Contract No. U-25/12l142C-L46C|zOLg-Med v FOR RC l43C




Prefetence Description of storcs accephd

366c Enoxaparin 60 mg/0.6m1 Inj-Each PFS to contain: Enoxaparin 60 mg/0.6m1

1 PFS

1 PFS FIRST

Bharat Serums AndVaccines Limited

Midas CarePharmaceuticalsPr^. Ltd.

184.30 PerI PFS

200.00 Per l PFS

1 PFS

215.00 Per 1 PFS

1 PFS

0,65 Perdose

Rupees Two Hundrcd Only

VOXAPARIN 60SAME AS IN ITEM

SECOND TOMOH 60 MG

SAME AS IN ITEM

THIRD TONOPIN 6OMG

SAME AS IN ITEM

Rupees TWo Hundrcd Fifteen Only

Fluticasone + Salmeterol Inhaler-

Each Metered Dose to contain: Salmeterol 25mcg,

Fluticasone 50mcg


20 TabsBottle

FIRST

240 MDI FIRST

R Nil AND Paise Six Five On

FLUSAL 50 INHALATIONSAME AS IN ITEM

K-COR 5SAME AS IN ITEM

Rupees One AND Paise Six Zeru Onlyz

l Tab/Cap423a Nicorandil Tab/Cap-

Each Tab/Cap to contain: Nicorandil 5mg

Page 43 of 50

ftem No

Firm Name

Virchow BiotechA^. Ltd

EmcurePharmaceuticalsrtd


Rurees One Hundtd Eighty Four AND Pai* Thrce Zero Only

1.60 Perl Tab/Cap

420a



Prefetence Dexription of storcs acephd

433b Sodium Valproate + Valproic Acid CR Tab/Cap-Each CR Tab/Cap to contain:(Sodium Valproate + Valproic Acid) Eqv. to Sodium

Valproate 500mq.

1 Tab/Cap


1.78 Perl Tab/Cap

1O Tabs FIRST NEW VAT CR 5OO

SAME AS IN ITEM


1.79 Per 10 Tabs SECOND TAB VALATE CHRONO 500l Tab/Cap SAME AS IN ITEM

Sanofi - Synthelabo(India) PrivateLimited

Rupees One AND Paise Seven Nine Only

7,78PEr 10 Tabs THIRD VALPARIN CHRONO 5OO


Rupes Seven AND Paise Seven Eight Only

Propranolol Tab/Cap-

Each Tab/Cap. to contain: Propranolol 40mgl lab/Cap


1.32 Perl Tab/Cap

6.00 Perl Tab/Cap

10 Tabs FIRST

10 Tabs FIRST

Rupees Six Onl2

PROVANOL-40

SAME AS IN ITEM

COVERSYT 2MGSAME AS IN ITEM

R One AND Paise Thrce TWo

1 Tab/Cap

Page 44 of 50

Employees' State f nsu ra nce Corpration

Rate Schedule of Running Rate Contract No, U-25ll2ll42C-t46cl2OLg-Med V FOR RC 143C

Valid from Thursday, October L4th 2O2, to Tuesday, October 31st 2023

Rupees One AND Paise Seven Eight Only

44b


470a Perindopril Tab/Cap-

Each Tab/Cap to contain: Perindopril 2mg

Employees' Sbte fnsurance Corporation

Rate Schedule of Running Rate Contract No. U-25/12l142C-l46Cl2OLg-Med V FOR RC 143C

Valid from Thursday, October L4rh 2O2l to Tuesday, October 31* 2023



Preference Description of stores acepfud

470c 1 Tab/Cap

10.06 Per 10 Tabs FIRST ZIMPRII.S

Rupees Ten AND Paise Zerc Six Only





l Tab/Cap

12.14 Perl Tab/Cap

1.51 Perl Tab/Cap

0.29 Per

l Tab/Cap10 Tabs FIRST

10 Tabs SECOND COVERSYL 8MGSAME AS IN ITEM

Rupees fwelve AND Paise One Four Only

bs FIRST RISAME AS IN ITEM

Rupees One AND Paise Five One Only

474b Olanzapine Tab/Cap-

Each Tab/Cap to contain: Olanzapine 5mg

l Tab/Cap

10 Ta

Rupees Nil AND Paise Two Nine Only

O.43 Per 10

OLANZAP.SSAME AS IN ITEM

SECOND OLZIC 5 MG

SAME AS IN ITEMTabs

l Tab/Cap

Rupees Nil AND Paise Four Thrce Only

473a Resperidone Tab/Cap-

Each Tab/Cap to contain: Resperidone 1mg

1 Tab/Cap

Page 45 of 50

Perindopril Tab/Cap-

Each Tab/Cap to contain: Perindopril Erbumine Bmg


P

Employes' State fnsuran@ Corporation

Rate Schedule of Running Rate Contract No.U-25lt2ll42o-l46cl2OL9-Med V FOR RC 143C

Valid from Thursday, October L4n' 2O2l to Tuesday, October 31st 2023

Packingftum No Drug Description

De*ription of s'torcs ac@phdFirm Rate/unit

FirmPacking

475b Haloperidol Tab/Cap-

Each Tab/Cap to contain: Haloperidol 5mg

1 Tab/Cap


Rupes One AND Pai* Four Four only

Amitripryline Tab/Cap-

Each Tab/Cap to contain: Amitriptyline 10mg

l Tab/Cap

10 Tabs FIRST




Zydus HealthcareLtd


t.44 Perl Tab/Cap

0.52 Perl Tab/Cap

0.83 Perl Tab/Cap

10 Tabs FIRST

loTabs FIRST

AMICON 10 MG

SAME AS IN ITEM

AMICON 25 MG

SAME AS IN ITEM

XET 10SAME AS IN ITEM

Rupes llil AND Paise Five Two Onll

Amitriptyline Tab/Cap-

Each Tab/Cap to contain: Amitriptyline 25mg

l Tab/Cap

Rupees Nil AND Pai* Six One OnlY

486a l Tab/Cap

Rupees Seven AND Paise Eight Five Onlyn

Firm Name Ptefercnce

477a

0.61 Perl Tab/Cap

477b

Paroxetine Tab/Cap-

Each Tab/Cap to contain: Paroxetlne 10mg

Rupees Nil AND Paise Eight Thtee Only

7.85 Per 10 Tabs SECOND PEXEP-IO


l"-YPage 46 of 50

Packingftem No Drug Desciption

Firm Rate/unit Packinq

Prefetence Dexription of storcs acepted

486b Paroxetine Tab/Cap-

Each Tab/Cap to contain: Paroxetine 20mg

1 Tab/Cap

Zydus HealthcareLtd


Cipla Limited

MacleodsPharmaceuticalsLimated

1.39 Perl Tab/Cap

0.57 Perl Tab/Cap

3,40 Perl Tab/Cap

Rupees One AND Paie Th,ee Nine Only

11.05 Per 10 Tabs SECOND PEXEP-2O

l Tab/Cap SAIIE AS IN ITEM

Eleven AND Paise Zero Five

10 Tabs FIRST XET 20SAME AS IN ITEM

loTabs FIRST

10 Tabs THIRD METOMAC 50SAME AS IN rTEMz

Ruryes Nil AND Paise FiYe Seven Only

0.65 Per 15 Caps. SECOND METOTARXR 50l Tab/Cap (HARD GELANN EXTENDED.

RELEASE CAPSULE)

SAME AS IN ITEM

Rupees Nil AND Paise Six Five Only

l Tab/CapMetoprolol ER Tab/Cap-

Each ER Tab/Cap to contain:

f4etoprolol Succinate 47.5m9Metoprolol Tartrate 50mq.

Equivalent to

525a

Page 47 of 50

Employees' State fnsurance Corpration

Rate Schedule of Running Rate Contract No. U-25/121142C-l46Clz0l9-Med V FOR RC 143C


Firm Name


METTOC ER 50SAME AS IN TTEM

Rupees fhree AND Paise Four Zeto Only

*

Employes' State fnsu ra nce Corporation

Rate schedule of Running Rate contract No. u-25l12l142c-t46cl2ol9-Med v FoR Rc 143c


Drug Packing

Firm Name Firm RaE/unit

FirmPackins

Prefercnce De*ription of stores ac@pted

527a Gabapentin Tab/Cap-

Each Tab/Cap to contain: Gabapentin 300mg1 Tab/Cap

SignaturePhytochemicalIndustries



1.19 Perl Tab/Cap

1.74 Per 1O Capsl Tab/Cap

0.88 Perl Tab/Cap

SECOND GABAZIM 3OO

SAME AS IN ITEM


Rupees One AND Paise One Nine Only

2.23Per 10Tabs THIRD PROGABA3OO MGI Tab/Cap SAME AS IN ITEM

Two AND Paise Two Three

l0 Tabs FIRST ZAPORIL 25 MGSAME AS IN ITEM

555a Clozapine Tab/Cap-

to contain: Clozapine 25mqEach Tab Ca

1 Tab/Cap

555b Clozapine Tab/Cap-Each Tqb/Cap to contain: Cloza pine 100m9

l Tab/Cap



1.67 Perl Tab/Cap

10 Tabs FIRST PIIZEP 1OO

SAME AS IN TTEM

Rupees One AND Paie Slx Seven Only

1.87 Per 10 Tabs SECOND ZAPORIL lOO MGl Tab/cap SAME As IN ITEM

Rupees One AND Pai* Eight*ven Only

ftem No


Rupees One AND Pai* Seven Four Only

Rupees Nil AND Paise Eight Eight Only

a

Page 48 of 50

'Jd.-'-t-.

Packingftem No Drug Description


Prefercnce Dexription of stores ac@pted

556a Escitalopram Tab/Cap-

Each Tab/Cap to contain: Escitalopram 10 mg

I Tab/Cap


0.42 Perl Tab/Cap

10 Tabs FIRST

10 Tabs FIRST



Rupees Nil AND Paise Four Two Only

0.64 Per 10 Tabs SECOND LEXADEP 10l Tab/Cap SAME AS IN ITEM

Rupees Nil AND Pai* Six Four Only

0.79 Per 10Tabs THIRD ESCIPRA 10 MG

l Tab/CaP SAME AS IN ITEM

Ruryes Nil AllD Paise Seven Nine Only

ES-TDO(ASAME AS IN ITEM

ESCIPRA 20 MG

SAME AS IN ITEM

556b Escitalopram Tab/Cap-

Each Tab/Cap to contain: Escitalopram 20 mg

l Tab/Cap

Rupees One AND Pai* Two Four Only

Dalteparin Sodium Inj-Each PFS to contain:

Dalteparin Sodium 2500 IU Units

1 PFS

1 PFS FIRST

L.24Perl Tab/Cap

157.98 Per1 PFS

Rupees One Hund,ed Fifty Seven AND Paise Nine Eight Only

Page 49 of 50

Employees' State Insuran@ C.orporation

Rate Schedule of Running Rate Contract No. U-25/121142C-l46ClzOLg-Med V FOR RC 143C

Valid from Thursday, October 14th 2021 to Tuesday, October 31d 2023

Firm Name

FRAGMIN 25OO IUManufactured By:-M/s. Pfizer ManufacturingBelgium NV Rijksweg 12Puurs NA(Belgium), B-2870BelgiumSAME AS IN ITEM

..4?


Pfizer PrcductIndia Private Ltd

557a

ft

Employes' SbE fnsurance CorPoration

Rate Schedule of Running Rate contract No. U-25/121142C't46Cl2OLg-Med V FOR RC 143C

Valid from Thurcday, October 14th 2021 to Tuesday, October 31"t 2023

ftem No

Description of stores accePbdPreferenceFirm Rate/unit

1 PFSDalteparin Sodium Inj-

Each PFS to contain:

Dalteparin Sodium 5000 IU Unlts

557b

Pfizer ProductIndia Private Ltd

Windlas BiotechPrivate Limited


Bharat Serums And

Vaccines Limited

0.70 PerI Tab/Cap

4.65 Perl Tab/Cap

883.00 Per

l Vial

IOTAbS FIRST

10 Tabs

FRAGMIN SOOO IUManufactured BY:-

M/s. Pfi zer ManufacturingBelgium NV Riiksweg 12

Puurs NA(Belgium), B-2870

BelgiumSAME AS rN rrEM7.

FIXOHEAM.25OSAME AS IN ITEM

THROMBOFLUX 75OOOO I.U

SA]{E-.AS..II.{ ITEM

Rupees Nil AND Paise Seven Zero Only

SECOND BOTROSTATTABLETS

SAME AS IN ITEM a.

Rupees Four AND Paise Six Five OnlY

l Vial FIRST

Rupees Eight Hundrcd Eighty Three Only.

l Tab/CapEthamsylate Tab/CaP-

Each Tab/Cap to contain Ethamsylate 250 mg68a

Streptokinase Inj-

Each Vial to contain: Streptokinase I.P 7.5 Lac IU74a

Firm NamePa*inq

1 PFS FIRST260.23 Per

1 PFS

---

Rupees Two Hundrcd Sixty AND Paise TWo Thte Only

1 Vial

,

Page 50 of 50 lT

gentral rate contract no. - 143(c) - for supply of drugs & dressings

Documents

Transcript of gentral rate contract no. - 143(c) - for supply of drugs & dressings